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CHAPTER I
LITERATURE REVIEW
Chemical and Physical Structure of Wood
The chemical and physical structure of wood is a key component in the intricate
process of wood degradation by microbial organisms. Wood has two basic domains: the
void space and the woody cell wall. The void space, or lumen, helps to conduct water,
while the cell wall establishes the environment within the cell (Wiedenhoeft 2010). The
cell wall is composed of various layers: the middle lamella, the primary cell wall, and the
secondary cell wall. Also within the cell wall, there are both primary and secondary
components. The primary structural components, constituting the bulk of the cell wall,
establish the chemical and physical nature of the cell wall. The secondary non-structural
components give various characteristics to the wood (Panshin and deZeeuw 1980). Each
of the structural and chemical components is essential to the structural utility of wood
products in use today.
Primary or chemical components of the wood cell wall consist of 40-50 %
cellulose, 20-35 % hemicelluloses, and 15-35 % lignin; each varying slightly based on
wood species (Panshin and deZeeuw 1980). Cellulose functions as the main structural
component providing strength in the cell wall and can exist as a primary and/or secondary
structure. The primary structure consists of a generally linear, un-branched chain of βglucopyranose residues (5-7 µm) connected via a 1,4-β-glycosidic bond with every
second residue rotated 180° forming a cellobiose (1.03 nm) residue. The secondary
1

structure consists of long narrow sheets bundling together to form a crystalline structure
(40 µm) with regions of ordered fibrils and semi-ordered fibrils (Henriksson 2009).
Hemicellulose exists as mixtures of xylans or glucomannans in the cell wall based on the
species of the wood. It helps form the structural integrity of the cell wall by closely
associating with cellulose and binding the fibrils to lignin (Teleman 2009). Lignin exists
as a three-dimensional matrix polymerized from varying percentages of three monomers:
p-coumaryl alcohol, coniferyl alcohol, and/or sinapyl alcohol, based on wood species.
Generally, lignin functions to provide rigidity to the cell wall, join cell wall components
together, and make the cell wall hydrophobic (Henriksson 2009). In general, all layers of
the cell wall are composed of cellulose fibrils surrounded by hemicellulose molecules
organized in a ribbon-like structure, with lignin inhabiting the left over vacant spaces
(Pereira et al. 2003).
Secondary cell wall components have no influence on structural associations in
the wood. Instead, these components play a role in providing the wood with particular
characteristics, like biological resistance, color, and odor (Panshin and deZeeuw 1980).
These secondary components represent a very small portion of the wood and are typically
found in very low quantities within a species. However, even in such low quantities, it is
possible for these components to exist in a wide variety of different molecules (Pereira et
al. 2003). Usually, these components consist of extraneous material, or extractives, and
ash (Panshin and deZeeuw 1980). Extractives represent a wide range of organic
compounds like, terpenoids, phenolic constituents, fats, and waxes. Terpenoids, derived
from isoprene (C5H8) units, consist of monoterpenoids (2 isoprene units),
sesquiterpenoids (3 isoprene units), diterpenoids (4 isoprene units), triterpenoids (6
isoprene units), steroids, and polyterpenoids (> 8 isoprene units). Terpenoids are found
2

in the resin of softwoods and exist in all forms; however, in hardwoods, only the higher
terpenoids are found (Pereira et al. 2003; Sjöström 1993). The most common phenolic
constituents are stilbenes, lignans, hydrolysable and condensed tannins, and flavonoids,
and are commonly located in the heartwood and bark. These phenolic compounds
contribute to protect the wood from microbial and fungicial attack (Sjöström 1993). Fats
(esters of glycerol with long-chain fatty acids) and waxes (esters of long-chain alkanols
with fatty acids) exist in small quantities and affect the permeability of the wood (Pereira
et al. 2003). Inorganic components, like ash, make up approximately one percent of the
dry weight and consist of various metals like, calcium, potassium, and magnesium, and
metal salts such as, carbonates, silicates, and phosphates (Sjöström 1993). Additionally,
the presence of secondary cell wall components is also related to permeability and certain
physical properties, like specific gravity, hardness, and strength (Panshin and deZeeuw
1980).
The distribution, orientation, and proportion of chemical components largely vary
for each of the wood cell wall layers. The primary function of the middle lamella is to
join neighboring cells together. Because of this, the middle lamella is composed mostly
of lignin, which allows adherence of these neighboring cells. The primary cell wall,
usually undistinguishable from the middle lamella, is a thin layer characterized by a
random, unorganized arrangement of cellulose fibrils. It has high lignin concentrations
and low cellulose concentrations (Pereira et al. 2003). The secondary cell wall (high in
cellulose concentrations) is composed of three layers: S1, S2, and S3, and are
distinguished by the change in cellulose fibril angles. The thin S1 layer cellulose fibrils
are laid relatively horizontally (50°-70°). Cellulose fibrils in the thick S2 layer are almost
perpendicular (5°-30°) to that of the S1 layer. The S2 layer, because of its thickness and
3

fibril orientation, has the greatest affect on the strength properties of the wood. The S3
cellulose fibrils are oriented similar to the S1 layer (> 70°). Because of the “Z”
orientation of cellulose fibrils within the S1, S2, and S3 layers, the secondary cell wall is
largely responsible for the strength properties of wood (Panshin and deZeeuw 1980;
Sjöström 1993; Wiedenhoeft 2010).
Wood Biodeterioration
Decay can be defined as the deterioration of the wood cell wall by some
biological manner, resulting in a loss of strength properties. Wood is easily susceptible to
a variety of biological agents because of its porous-like nature. Certain biological agents
like, bacteria, fungi, insects, and mold have the potential to cause severe deterioration of
various wood-based materials. One of the most detrimental organisms causing wood
deterioration are the decay fungi because they can initiate severe cell degradation by
consuming the structural materials within wood. When attacked by decay fungi, the
wood results in a loss of physical and mechanical properties brought upon by a softening
or weakening of the wood itself. Fungal growth depends on a variety of factors: a food
source (breakdown of cell wall components), water (wood fiber saturation point above
30%), favorable temperature (between 20-32 °C), sufficient oxygen, and an acidic
environment (pH: 2-6) (Shmulsky and Jones 2011; Clausen 2010).
Fungal decay can be classified into two major types: brown-rot and white-rot.
Typically, brown-rot and white-rot fungi belong to the Basidiomycota family. Both
brown-rot and white-rot fungi attack wood cells via hyphael growth through bordered pits
and secrete enzymatic and non-enzymatic metabolites to obtain nutrients from the wood
cell walls. Brown-rot fungi commonly attack coniferous (softwood) species, while
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white-rot fungi are more common to the hardwood species. These two types of decay
fungi breakdown and utilize wood components by two uniquely different mechanisms.
Brown-rot fungi have both enzymatic and non-enzymatic mechanisms to remove the
cellulose and hemicellulose components leaving the wood a dry, crumbly, powdery,
lignin-rich brown mass. White-rot fungi can uniformly or selectively remove the lignin,
cellulose, and hemicellulose leaving the wood in a bleached, stringy, spongy mass. The
white-rot fungi can have both cellulolytic and lignin-degrading enzymes while the
brown-rot fungi only posses the cellulolytic enzymes (Goodell et al. 2008). Both brownrot and white rot organisms reduce the pH of the wood during colonization and incipient
decay, but it has been shown that brown-rot organisms can drive the pH lower than the
white-rot organisms can (Green et al. 1991; Goodell 2003).
White-rot Decay
White-rot fungi are one of the few organisms to cause complete degradation of
the wood structure and all wood cell wall components (Nilsson 2009). Wood decay by
white-rot fungi is extremely variable and can be classified by the way cell wall
components that are broken down. White-rot organisms utilize a simultaneous (nonselective) decay mechanism to breakdown cellulose, hemicellulose, and lignin at a
uniform rate within the wood. This type of decay starts by the erosion of the lumen
followed by extensive degradation of all cell wall components then finally degradation of
the middle lamella (Messner et al. 2003). Selective decay breaks down hemicellulose
and lignin and leaves the cellulose relatively un-degraded. In this type of decay, the
degraded wood has certain areas that appear more fibrous due to the destruction of lignin
and hemicellulose. Typically, simultaneous white-rot decay is the most common form of
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white-rot decay in wood products. Certain species of white-rot fungi are capable of
performing both simultaneous and selective decay mechanisms at the same time on the
same piece of wood (Goodell et al. 2008; Messner et al. 2003).
White-rot fungi decay wood enzymatically by utilizing certain mechanisms to
oxidize and mineralize cellulose, hemicellulose, and lignin. Cellulose is hydrolyzed at
the β-1,4-glycosidic linkage producing carbon and energy sources for cellulotic
microorganisms (Pérez et al. 2002). To degrade cellulose, white-rot fungi produce
endoglucanases, cellobiohydrolases (exoglucanases), and β-glucosidases, which actively
degrade the crystalline cellulose. Endoglucanases hydrolyze internal bonds in both
amorphous and crystalline regions, which release newly formed terminal ends.
Cellobiohydrolases efficiently breakdown crystalline cellulose and degrade chains
generated by endoglucanases. β-glucosidases break the bonds between cellobiose units.
Complete degradation of hemicellulose to monomeric sugars and acetic acid is achieved
by a variety of hydrolytic enzymes including, xylanases, xylosidase, esterases,
glucuronidases, and arabinofuranosidase (Pérez et al. 2002; Goodell et al. 2008).
Xylanases cleave xylan and generate oligosaccharides, while xylosidases attack those
oligosaccharides to generate xylose. Esterases, glucuronosidases, and
arabinofuranosidases act as accessory enzymes and aid in the hydrolysis of xylans and
mannans (Pérez et al. 2002). The main lignin degrading enzymes produced by white-rot
fungi are lignin peroxidase, manganese peroxidase and laccase. Lignin peroxidase can
degrade phenolic and non-phenolic lignin, while manganese peroxidase and laccase can
only degrade phenolic lignin (Li 2003). Lignin peroxidase cannot penetrate the cell wall
and is limited to the exposed components on the cell wall surface. In the presence of
hydrogen peroxide, lignin peroxidase produces a veratryl alcohol radical that can
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penetrate into the cell wall to access intracellular components. Manganese peroxidase
oxidizes Mn2+ to Mn3+, which can diffuse into the cell wall and degrade phenolic lignin
compounds. Laccase uses oxygen as an oxidizing reagent to degrade phenolic lignin
compounds (Goodell et al. 2008).
Brown-Rot Decay
The largest threat to the destruction of coniferous wood in service is the result of
brown-rot fungi (Goodell 2003). These organisms are capable of utilizing two different
methods to decay wood: a non-enzymatic and an enzymatic mechanism. In the initial
stages of decay, brown-rot fungi must first attack the hemicelluloses before accessing the
cellulose. This initial step is critical for the organism to establish itself in the wood
(Green and Highley 1997). Following hemicellulose degradation, cellulose is rapidly
depolymerized and results in strength loss of the wood at a very early stage. During its
attack on the cellulose and hemicellulose, it is hypothesized that the brown-rot fungi
chemically modify the lignin via demethoxylation and demethylation; however, these
organisms are not capable of fully depolymerizing lignin in the process. The
modification of lignin is carried out through an enzymatic mechanism (Nilsson 2009; Xu
and Goodell 2001).
The hyphae produced by the brown-rot fungi can secrete both enzymatic and low
molecular weight metabolites, channel them into the cell wall, and actively breakdown its
components (Nilsson 2009). Typically, the Fenton reaction is associated with early
stages of decay and must occur away from the fungal hyphae to avoid the produced
reactive oxygen species from destroying the hyphae. In non-enzymatic decay, brown-rot
fungi produce low molecular agents that are responsible for cell wall depolymerization by
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free radical production (.OH) via the Fenton reaction (Fe2+ + H2O2  Fe3+ + .OH + OH-).
Extracellular hydrogen peroxide (H2O2) reacts with ferrous iron (Fe2+) creating hydroxyl
radicals (.OH) that are able to diffuse through the cell wall and degrade hemicellulose
(Xu and Goodell 2001). For the Fenton reaction to occur, brown-rot fungi require certain
mechanisms to solubilize iron from iron oxides, to reduce Fe3+ to Fe2+, and to produce
H2O2 (Arantes et al. 2009).
Several mechanisms have been proposed for the production of Fenton reagents;
however, the production of these reagents mainly relies on certain metabolites, like
oxalate, and low molecular weight compounds with the capability to reduce Fe3+. It has
been shown that brown-rot fungi produce phenolate-type low molecular weight
compounds with the ability to reduce Fe3+ and promote .OH production. Metabolites
produced by brown-rot fungi, like oxalate, have the potential to obtain iron from ironoxide complexes by creating a pH gradient between the fungal environment and the cell
wall. Once iron is obtained, it forms an iron-oxalate complex, which can diffuse into the
cell wall (Arantes et al. 2009). Little cell wall material is metabolized in the early stages
of decay by brown-rot fungi (Goodell et al. 2008). Initial attack by brown-rot fungi is
localized in the S2 layer of the cell wall then moves throughout the S1 and S3 layers as it
progresses (Nilsson 2009). The S3 layer remains untouched until late stages of decay and
the porosity of this layer is relatively unchanged (Green and Highley 1997).
In the enzymatic mechanism, brown-rot fungi produce endoglucans and
exoglucanases to cleave the β-1,4- glucosidic linkages between cellulose monomers and
β-glucosidases to hydrolyze the cellobiose units but lack cellobiohydrolase and
exoglucans. To breakdown hemicellulose, these organisms utilize endoxylanases and βxylosidases. Coniophora puteana is the only known brown-rot fungus capable of
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producing cellobiohydrolase and cellobiose dehydrogenase. Because these extracellular
enzymes are too large to penetrate the wood cell wall, it has been established that
cellulose degradation mainly occurs via a non-enzymatic mechanism in initial decay by
brown-rot fungi (Green and Highley 1997; Xu and Goodell 2001; Goodell 2003).
Copper-based Preservatives
Naturally durable wood products have the ability to resist attack by various
biological agents, whereas, a majority of current wood species used in forest products
that will be in contact with the environment are non-resistant to decay. Because of the
high biodegradability of these products, preventative measures to protect the wood are
needed. Pressure treatment with wood preservatives is the most common form of
protection for wood products. The use of preservative treatments significantly extends
the service life of wood-based products. Protection is dependent upon penetration and
retention levels of the various chemicals within the wood (Shupe et al. 2008). The
effectiveness of wood preservatives depends on sufficient protection against a variable
range of wood-inhabiting organisms, low environmental impact, and low mammalian
toxicity (Lebow 2004; Shmulsky and Jones 2011).
Current commercial preservatives in use today are classified as oil-based or
water-borne formulations and generally have broad-spectrum toxicity against various
organisms. The basic difference between the two is the type of liquid (oil or water) used
to transport the toxic chemical into the wood (Shmulsky and Jones 2011; Shupe et al.
2008). The most common types of oil-based preservatives are creosote, copper oxine,
copper naphthenate, and pentachlorophenol. Wood treated with preservatives that use
volatile solvent carriers have the potential to cause shrinking upon moisture loss after the
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treating process. Less-volatile oils, like creosote, protect from weathering, but could
have negative influences on cleanliness, odor, color, paintability, gluability, and fire
resistance. Wood treated with oil-based preservatives is not recommended for
residences, enclosed structures, or regular contact with humans (Shupe et al. 2008).
Water-borne preservatives are applied as aqueous solutions or use water as the carrier and
become chemically “fixed” and stabilized within the wood (Lebow 2010). Common uses
for wood treated with water-borne preservatives are residential, construction, and other
various products intended for use outdoors. Most water-borne preservatives utilize
copper (II) and are the most common form of protection for softwood species used
mainly in residential applications. Problems associated with water-borne preservatives
include drying and shrinking of treated wood, increased risk of corrosion, inability to
treat hardwood species, and the lack of water repellency (Lebow 2010; Shupe et al.
2008).
Between the late 1970s and 2004, the most commonly used wood preservative
was a water-borne preservative, chromated copper arsenate (CCA), because it was
economical and provided broad-range protection against various types of deterioration
(Lebow 2010). Three main formulations (CCA-A, CCA-B, and CCA-C) have been
successful in providing long-term protection of treated wood products; however of the
three formulations, CCA-C achieves greater efficacy against wood-inhabiting organisms
and resistance against leaching. CCA-C active components consist of 47.5% chromium
trioxide, 34% arsenic pentoxide, and 18.5% copper oxide (Lebow 2010). CCA-C is
efficacious because copper provides protection against fungi, arsenic provides protection
against copper-tolerant fungi and termites, and chromium fixes the copper and arsenic
into the wood (Freeman and McIntyre 2008). In 2004, due to voluntary label changes,
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the Environmental Protection Agency (EPA) restricted the use of CCA to industrial
applications (Lebow 2004; Lebow et al. 2004; Freeman and McIntyre 2008; Lebow
2010). Because of this restriction, the American Wood Preservers’ Association (AWPA)
continues to standardize a variety of chromium and arsenic-free formulations, which
utilize copper as the primary ingredient (Lebow 2004).
Today, copper is the primary component used to protect wood for residential
applications because it exhibits algaecide, bactericide, fungicide, insecticide, and
moldicide properties (Freeman and McIntyre 2008). Unlike the majority of organic
molecules, copper possesses efficacy against a wide variety of wood-inhabiting
organisms including the decay fungi. Other advantages of using copper as a primary
component of protection include the capacity to easily create a variety of formulations,
the ability to easily analyze and assess penetration levels, and it has been shown to slow
photodegradation by UV radiation and water. The use of copper as the primary form of
protection can pose certain problems including tolerance, corrosivity, and aquatic
toxicity. Tolerant organisms have the ability to grow and thrive in the presence of high
concentrations of toxic metals, specifically copper. Due to the threat of tolerant
organisms, copper-formulations are usually combined with an organic co-biocide for
further protection. Typically, common copper co-biocides used are quaternary
components and azoles (Shupe et al. 2008).
The restriction of CCA – treated wood in the residential market led to the
development of several alternative preservative treatments utilized by the industry today.
Table 1 outlines these alternative copper-based preservatives, categorizes them based on
formulation, and details the percentage of components found in each preservative (Lebow
2004; Lebow et al. 2004; Freeman and McIntyre 2008; Lebow 2010). In recent years,
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water-borne micronized copper formulations have emerged as an alternative formulated
preservative. The micronized particles are produced by the mechanical grinding of
copper in water-borne or oil-borne compounds and are aided by a dispersal agent. This
process results in approximately 90 percent of the copper particles being less than 1000
nm in size. Typically, polymeric dispersants are used as the dispersing agents and allow
the attachment of particles to the surface of the wood as well as maintain distance
between the particles. Micronized particles are believed to be “fixed” into the wood by
strong adhesion between the dispersant and wood fiber (Freeman and McIntyre 2008).
Micronized formulations in use today contain a smaller percentage of copper and are
considered more environmentally favorable. The variety of copper-based wood
preservatives continues to increase as a result of various biocidal properties demonstrated
by copper; however, the formulations need to be used in the capacity intended.
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Table 1.1

Copper-based Wood Preservatives

Preservative

Formulation
Type

Acid Copper Chromate (ACC)

Water-borne

Alkaline Copper Quat (ACQ-A)

Water-borne

Alkaline Copper Quat (ACQ-B)

Water-borne

Alkaline Copper Quat (ACQ-C)

Water-borne

Alkaline Copper Quat (ACQ-D)

Water-borne

Ammoniacal Copper Citrate (CC)

Water-borne

Copper Azole (CBA-A)

Water-borne

Copper Azole (CA-B)

Water-borne

Copper Azole (CA-C)

Water-borne

Copper bis
(dimethyldithiocarbamate) (CDDC)

Water-borne

Copper Naphthenate (CuN-W)

Water-borne

Copper Naphthenate (CuNap)

Oil-borne

Copper Xyligen (Copper HDO) (CXA)
Oxine Copper (Copper-8quinolinolate)

Water-borne

Oil-borne

Proportion of Components
31.8% Copper oxide
68.2% Chromium trioxide
50% Copper oxide
50% Didecythyl ammonium chloride
67% Copper oxide
33% Didecythyl ammonium chloride
67% Copper oxide
33% Alkylbenzyldimethyl ammonium
chloride
67% Copper oxide
33% Didecythyl ammonium chloride
62% Copper oxide
38% Citric acid
49% Copper
49% Boric acid
2% Tebuconazole
96% Copper
4% Tebuconazole
96% Copper
2% Tebuconazole
2% Propiconazole
17-29% Copper oxide
71-83% Sodium dimethyldithiocarbamate
Reaction product of copper salts and
naphthenic acid
Dissolved in alkanolamine/ammonia in
water
61.5% Copper oxide
14% Bis-(N-cyclohexyl-diazenium
dioxy) copper
24.5% Boric acid
10% Copper-8-quinolinolate
10% Nickel-2-ethylhexanoate
80% Inert ingredients

In the early 2000s, AWPA developed a guideline to classify preservatives
appropriately. The Use Category System (UCS) standards detail specific uses, retention
levels, penetration requirements, and severity of deterioration. Use Category 1 (UC-1),
the lowest category, is used when the wood is intended for interior construction and is
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completely protected from the elements. UC-2 is intended for interior construction and is
exposed to occasional dampness. UC-3 is intended for above ground use, while UC-4 is
intended for in-ground contact of exterior applications. UC-5 is used for wood in contact
with seawater (Lebow 2004; Lebow et al. 2004). Table 2 provides information about the
intended application for each of the copper-based preservatives listed above (Lebow
2006). Extensive testing is required to accurately evaluate these properties. AWPA
Standards require that testing be conducted when evaluating both new and existing
preservative formulations. Testing protocols include, but is not limited to, laboratory
leaching tests which evaluates how quickly a treatment is utilized; laboratory decay tests
which exposes the wood to aggressive fungal decay organisms or termites; field stake
evaluation which exposes the wood to the natural environment; above-ground field tests
which compares deterioration between untreated wood and preservative treated wood;
and corrosion, treatability, and strength testing (Lebow 2010).
Table 1.2

Intended Application for Copper-based Preservatives

Preservative
Acid Copper Chromate (ACC)
Alkaline Copper Quat (ACQ-A – ACQB)
Ammoniacal Copper Citrate (CC)
Copper Azole (CBA-A – CA-C)
Copper bis(dimethyldithiocarbamate)
(CDDC)
Copper Naphthenate (CuN-W, CuN)
Copper Xyligen (Copper HDO) (CX-A)
Oxine Copper (Copper-8-quinolinolate)
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Application
Direct contact with the ground
Direct contact with the ground
Direct contact with the ground
Direct contact with the ground
Direct contact with the ground
Direct contact with the ground
Direct contact with the ground
Above ground, fully exposed to the
weather

The use of copper as a primary component for the development of wood
preservatives continues to prevail despite the ability of tolerant organisms to circumvent
copper toxicity. Organic co-biocides are included to inhibit tolerant fungi; however,
these co-biocides are not always effective (Freeman and McIntyre 2008). There has been
some research into the development of preservatives that lack copper or other heavy
metals. These particular formulations rely on combinations of organic fungicides and
insecticides, and could possibly create alternative problems such as the breakdown of the
preservative by non-wood degrading organisms (Lebow 2006). To develop preservatives
that are effective in stopping all forms of biological attack, it is clear that additional
research into the mechanism of copper – tolerance is needed.
Copper Tolerance
The risks associated with using copper as a primary treating agent is the
possibility for organisms, specifically fungi, to tolerate or successfully resist the toxic
effect. These organisms are able to survive in less – than ideal growth conditions by
evolving adaptation mechanisms (DeGroot and Woodward 1999; Hall 2002). Green and
Clausen (2003) defined tolerance as the relative ability of an organism to grow and thrive
when subjected to an unfavorable environmental factor or toxin. Specifically, copper
tolerance is defined as the ability of an organism to grow and thrive in the presence of
copper ions (Hastrup et al. 2005). In comparison to other organisms, fungi have the
possibility to be extremely tolerant of toxic metals in high concentrations (Freeman and
McIntyre 2008). Copper-tolerant fungi have the ability to decay copper treated wood in
which the concentration of copper is higher than 1.6 mM/l (Gadd 1993). These particular
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organisms can detoxify copper in copper-treated wood, which enables toleration of
environments containing high concentrations of toxic metals (Hastrup et al. 2005).
Fungicides require certain characteristics like high uptake levels and numerous
active sites to be effective. In fungal cells, initial uptake of copper by ion exchange is
followed by permeation throughout the cell, and eventually leads to accumulation aided
by unspecific reactions within cell constituents (Somers 1963). Affinity, distribution, and
accumulation vary with species. Numerous characteristics make copper an ideal
fungicide. Excess copper causes damage through the oxidation of proteins, enzymes, and
lipids, which can lead to the interference of certain enzymatic processes. It can also
inhibit intracellular enzymes responsible for the destruction of lignocellulosic materials,
interrupt transport of nutrients in and out of the cell by binding to the cell wall, and cause
denaturation of proteins and enzymes which eventually leads to cell death (Freeman and
McIntyre 2008).
Tolerance is particularly variable with respect to preservative formulations, fungal
species, and even fungal isolates (Hastrup et al. 2005; Freeman and McIntyre 2008). The
majority of copper-tolerant fungi is classified as brown-rot basidiomycetes and is found
in the genera Fibroporia (Antrodia), Postia, Serpula, Laetiporus, Meruliporia,
Gloeophyllum, Tyromyces, and Wolfiporia (DeGroot and Woodward 1999; Green and
Clausen 2005; Arango et al. 2009; Clausen and Jenkins 2011; Schilling and Inda 2011).
Studies utilizing copper naphthenate were not successful in preventing attack by tolerant
organisms (Sutter et al. 1983). However, oxine copper has been shown to provide
exceptional protection against tolerant fungi. Clausen and Green (2003) showed the
inability of Postia placenta, Wolfiporia cocos, Meruliporia incrassata, and Antrodia
vaillantii to produce specific metabolites, which aid in the breakdown process when
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exposed to oxine copper. DeGroot and Woodward (1999) used Serpula lacrymans in
agar plate assays against CCA and agar block tests against copper napthenate and
determined a difference in tolerance of the isolates in relation to the two preservatives.
Treatments with ammoniacal copper citrate exposed to Serpula lacrymans have also
shown variation in breakdown ability (Freeman and McIntyre 2008). Collet (1992) found
that isolates of Antrodia vaillantii varied drastically in their tolerance to copper (Green
and Clausen 2003). Pohleven and Humar (2002) conducted studies on Norway spruce
with preservatives used in the European market and observed variability of copper
tolerance when exposed to Antrodia spp. (Green and Clausen 2005). Because of the high
variability associated with tolerance, it is apparent that these organisms must employ
numerous mechanisms to overcome preservative treatments.
There are many theories attributed to the mechanism of copper tolerance. Clausen
and Green (2003) stated that the “interaction of a number of diverse factors such as
growth rate, pH, oxalic acid production, and decay capacity all contribute to copper
tolerance”. The mechanism of tolerance associated with copper-tolerant fungi has most
commonly been connected to the production of oxalate (Green and Clausen 2003, 2005;
Hastrup et al. 2006; Freeman and McIntyre 2008; Arango et al. 2009; Shilling and Inda
2011). High extracellular accumulation of oxalate initiates the precipitation of copper
into the insoluble form of oxalate (copper oxalate crystals), and renders the copper ion
inert (Green and Clausen 2003). These organisms have the ability to immobilize copper
by precipitating copper oxalate (DeGroot and Woodward 1999). Both copper oxalate and
calcium oxalate crystals are present in decayed wood treated with copper-based
preservatives (Freeman and McIntyre 2008). Another important factor related to copper
tolerance is the presence of a low pH environment, which is also stimulated by oxalate
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production (Green and Clausen 2005). Choi et al. (2002) showed spores from coppertolerant organisms did not germinate in the presence of copper because the spores lack
the ability to actively produce oxalate (Freeman and McIntyre 2008). Thus, oxalate
accumulation and precipitation of copper oxalate crystals plays an important role in the
mechanism of copper tolerance (Clausen and Green 2003).
It has been demonstrated that in a low pH environment, copper oxalate crystal
formation, and the production and accumulation of oxalate are not the only mechanisms
of copper tolerance in these organisms (Clausen et al. 2008). Alternative mechanisms
have been documented and include the trapping of metal ions by cell wall constituents,
altering ion uptake when membrane permeability of copper is low, extracellular
precipitation or chelation by metabolites, or complexing of metallothioneins and
phytochelatins intracellularly (Freeman and McIntyre 2008). In the presence of copper,
fungal reactions prompt the formation of a thicker cell wall and an increased extracellular
mucilaginous material (hyphal sheath). Copper treated Scots pine exposed to Coriolus
versicolor and Gloeophyllum trabeum demonstrated increased N-acetyl glucosamine
production correlating to the amount of chitin present, which is indicative of thicker cell
wall development. Experiments on Trametes versicolor in culture media containing
increased copper concentrations showed an increase production of extracellular
mucilaginous material leading to an increased tolerance to copper (Vesentini et al. 2006;
Freeman and McIntyre 2008).
Because these copper-tolerant organisms have the ability to overcome the
preventative measures in use today, it is critical that these mechanisms be investigated.
Knowing the exact mechanisms, organisms involved, and specific requirements would
give insight into the physiological intricacies of copper tolerance.
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Significance of Oxalate
The production of oxalate (C2O42-) occurs in large quantities by numerous classes
of fungi. Oxalate aids in establishing colonization and performs critical roles in fungal
metabolism (Dutton and Evans 1996). Also, oxalate assists in cleaving hemicellulose
side-chains, eventually depolymerizing hemicellulose and cellulose, which causes
significant strength loss in wood (Green et al. 1991). It is believed that oxalate is a
metabolic byproduct of incomplete glucose oxidation via malate in the tricarboxylic acid
(TCA) cycle or glyoxylate in the glyoxylate (GLOX) cycle (Schilling and Jellison 2005;
Hastrup et al. 2006). The majority of brown-rot fungi produce oxalate in detectable
amounts; however, its production is limited in white-rot fungi due to the existence of
oxalate decarboxylase (Hastrup et al. 2006). Intracellular oxalate decarboxylase breaks
down oxalate to carbon dioxide and formate, and is not present in brown-rot organisms
(Espejo and Agosin 1991; Hastrup et al. 2006). Without oxalate decarboxylase, wood
low in carbon and nitrogen has the potential to generate oxalate instead of carbon dioxide
from the TCA and GLOX cycles (Dutton and Evans 1996; Schilling and Jellison 2005).
Without oxalate decarboxylase or other alternative regulation mechanisms, oxalate has
the potential to accumulate as a function of fungal respiration (Schilling and Jellison
2005).
Role of Oxalate
Oxalate functions in a number of unique ways in brown rot fungi. It has been
theorized that oxalate functions in iron reduction, acid hydrolysis of cellulose,
detoxifying metals, and chelating calcium from pit membranes (Schilling and Jellison
2005). Specifically in brown-rot fungi, oxalate functions to rapidly lower pH in the
immediate environment, initiate depolymerization of hemicellulose side-chains, and
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precipitate calcium oxalate (Hastrup et al. 2006). Oxalate also functions as a chelator to
remove iron from iron-oxide complexes in the lumen. Another theorized, yet to be
confirmed function of oxalate is to reduce the pH near the hyphae, which creates a pH
differential between the fungal environment and the wood cell wall. The combination of
removing iron from iron-oxide complexes and reducing the pH allows metal reduction
away from the organism protecting it from oxidative damage (Arantes et al. 2009).
In the non-enzymatic decay mechanism utilized by brown-rot fungi, it has been
theorized that oxalate and other low molecular weight mediators aid in the reduction of
Fe3+. This reduction of Fe3+ promotes the generation of hydroxyl radicals via the Fenton
reaction. Schmidt et al. (1981) demonstrated that oxalate has the ability to increase the
activity of Fenton-based degradation by reducing Fe3+ to Fe2+. However, the reactivity of
Fe3+ is dependent upon the pH and concentration of oxalate in the surrounding areas. It is
possible that high oxalate concentrations could form extremely stable iron-oxalate
complexes, which would delay Fenton-based degradation (Arantes et al. 2009).
Initially, brown-rot basidiomycetes produce oxalate in large amounts; however
levels of accumulation and function vary based on genus and species. Some brown-rot
basidiomycetes produce oxalate for initial decay but do not accumulate significant levels
during the decay process. Other brown-rot basidiomycetes utilize oxalate throughout the
decay process resulting in normal levels of accumulation (Goodell 2003). Typically,
oxalate produced by these organisms exists as a dihydrate calcium oxalate crystals and is
persistent throughout the growth stage (Dutton and Evans 1996; Goodell 2003). Calcium
ions which are released during decay can precipitate oxalate to form calcium oxalate
crystals (Hastrup et al. 2006). The formation of calcium oxalate crystals plays a crucial
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role in regulating the pH of the environment and facilitating the occurrence of the lower
pH environments typically observed (Goodell 2003).
Undecayed wood has a pH that varies between 3 and 6. Brown-rot fungi lower
the pH of the environment (between pH of 1-3) following initial colonization, because
cellulolytic activity is inhibited in higher pH environments. The majority of brown-rot
fungi initiate pH reduction through the production of oxalate. The pH reduction is
critical in the function of extracellular enzymes used by the fungi to degrade the wood
(Goodell 2003). Green et al. (1991) demonstrated that oxalate functions to depolymerize
cellulose over a range of pH levels from 1.5 to 2.5. They also showed that low pH levels
are responsible for high strength loss in the initial stages of decay. This rapid drop in pH,
seen in the initial decay stage, has been proposed to serve as an important factor in the
decay process (Green et al. 1991). Management of pH levels and the development of pH
gradients between the hyphae and wood cell wall occur as copper oxalate crystals are
solubilized. It is possible that brown-rot fungi regulate pH by utilizing the crystalline and
acid forms of oxalate in certain environments (Goodell 2003).
Oxalate is a metabolic byproduct of the decay process, and is also a major factor
that leads to the tolerance of copper based preservatives. The presence of copper
stimulates a rapid production of oxalate, and then the copper is inactivated by the excess
oxalate (Green and Clausen 2005). The production of oxalate tends to vary with the type
of copper treatment and fungal species (Arango et al. 2009). Most brown-rot fungi
produce oxalate routinely; however, copper-tolerant fungi produce it in much higher
quantities as an induced response to copper. Green and Clausen (2005) found that
copper-tolerant fungi produce 2-17 times more oxalate in copper citrate – treated blocks
compared to untreated controls. They also found that at week four copper stimulated 6621

93% more oxalate production when compared to untreated controls (Green and Clausen
2005). Because oxalate plays a significant role in the decay process of copper-tolerant
fungi, a certain mechanism must be utilized for its production.
Biosynthesis of Oxalate
Several pathways have been proposed for the biosynthesis of oxalate in brown-rot
fungi; however, in recent years, many researchers have linked it to the tricarboxylic acid
(TCA) and glyoxylate (GLOX) cycles (Dutton and Evans 1996; Munir et al. 2000; Munir
et al. 2001; Yoon et al. 2002). Both the TCA and GLOX cycles produce extracellular
oxalate. The TCA cycle is localized in the mitochondria while the GLOX cycle takes
place in the glyoxysome (Dutton and Evans 1996). There are four key enzymes involved
in the synthesis of oxalate, namely isocitrate lyase, malate synthase, gloxylate
dehydrogenase, and oxaloacetase. Isocitrate lyase serves as a vital enzyme in the
production of oxalate (Munir et al. 2001). Both glyoxylate dehydrogenase and
oxaloacetase lead to the direct production of oxalate within the TCA and GLOX cycles
(Munir et al. 2001; Yoon et al. 2002).
Munir et al. (2001) investigated the role of oxalic acid biosynthesis in the coppertolerant fungus, Tyromyces palustris. This study hypothesized that 1 M of glucose is
converted to 2 M of oxalate rather than producing the traditional carbon dioxide from the
TCA cycle. They further suggested that oxalate production was coupled with energy
production, and proposed the overall oxidation of 2 M of acetyl-CoA, yielding 2 M oxalic
acid, generating a net amount of 4 NADHs and 2 ATPS (Munir et al. 2001). Figure 1.1
shows the proposed biosynthesis of oxalate from glucose in the TCA and GLOX cycles
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as suggested by Munir et al. (2001). Table 1.3 details the twelve enzymes required for
each of the reactions from Figure 1.1 (Munir et al. 2001).

Figure 1.1

Enzyme/ Enzyme pathways which may be utilized in some fungi to
produce oxalate; [1-12] corresponding enzymes listed in Table 1.3. (A) the
TCA cycle; (B) the GLOX cycle (Munir et al. 2001).
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Table 1.3

Enzymes of the TCA and GLOX cycles thought to be involved in oxalate
biosynthesis (Munir et al. 2001).
NUMBER
1
2
3
4
5
6
7
8
9
10
11
12

ENZYME
Isocitrate lyase
Isocitrate dehydrogenase
2-Oxoglutarate dehydrogenase
Succinate dehydrogenase
Fumarase
Malate dehydrogenase
Citrate synthase
Aconitase
Malate synthase
Oxaloacetase
Acetyl-CoA synthease
glyoxylate dehydrogenase

Using the Munir et al. (2001) study as a model (Figure 1.1, Table 1.3), it was
hypothesized that there are three unique pathways for oxalate production. One pathway
produces oxalate utilizing the TCA cycle only; another produces oxalate from the GLOX
cycle only; and the third switches from the TCA to the GLOX cycle to produces oxalate.
In the TCA cycle, fumarate is synthesized to malate via fumarase. Malate is then
converted to oxaloacetate via malate dehydrogenase; then, this leads to the production of
oxalate by oxaloacetase. Within the GLOX cycle, glyoxylate is converted to malate via
malate synthase. Malate is then converted to oxaloacetate by malate dehydrogenase and
that is converted to oxalate via oxaloacetase. In the third potential pathway, isocitrate is
synthesized in the TCA cycle and then produces glyoxylate utilized by the GLOX cycle
via isocitrate lyase. Glyoxylate is then converted directly to oxalate via glyoxylate
dehydrogenase. Therefore, using F. radiculosa, each of these enzymatic pathways were
evaluated in relation to oxalate production.
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Objectives of Research
Many studies have been conducted on oxalate production; however, little is
known about the mechanism utilized by copper-tolerant fungi. A better understanding of
this mechanism is crucial in developing alternative methods to decrease problems caused
by these particular organisms. The purpose of this study was to gain insight into the
biosynthesis of oxalate by which the brown-rot decay fungus, Fibroporia radiculosa,
regulates tolerance of copper-treated wood. Specific objectives of this study are as
follows:
1. Assess the variation of oxalate production of fifteen F. radiculosa isolates
exposed to copper-treated wood.
2. Evaluate select F. radiculosa isolates undergoing decay of untreated and coppertreated wood for enzyme activity in relation to oxalate production.
3. Examine select F. radiculosa isolates undergoing decay of untreated and coppertreated wood for the differential expression of genes associated with oxalate
production.
4. Propose a potential pathway involved in the production of oxalate.
5. Determine the effect of alternative applications of ammoniacal copper citrate in
relation to oxalate production of the select F. radiculosa isolates.
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CHAPTER II
MATERIALS AND METHODS
Preliminary Study One: Sequencing Analysis Results
Fungal Isolates
Fifteen isolates of Fibroporia radiculosa were obtained from the USDA Forest
Products Laboratory in Madison, WI. Specific isolates used for this analysis include:
Baxter-31, HHB-6386-SP, FP-103272-T, FP-105309-R, FP-105780-SP, FP-90848-T, L12451-SP, L-7878-SP, L-9318-SP, L-9414-SP, L-11659-SP, L-12617-SP, MJL-630-SP,
RLG-7629-SP, and TFFH 294.
Media Preparation
All isolates were maintained on 2% malt agar (BD, Fisher Scientific, Pittsburg,
PA) media plates. Six mm plugs were placed in 100 mL of 2% Malt Broth (BD, Fisher
Scientific, Pittsburg, PA) and grown for approximately 2 weeks in stationary culture.
Once mats of fungal mycelium were visible, contents of the flasks were filtered using
Whatman filter paper (Fisher). Mycelial mats were stored at -20°C until processed for
DNA.
DNA Extraction
DNA extractions were carried out using the NucleoSpin Plant II Kit (MacheryNagel). Each 50 mg fungal tissue sample was placed in a 2 mL screw-top tube with two
5 mm glass beads, 500 µl CTAB lysis buffer (2% cis-trimethyl ammonium boric acid,
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100 mM Tris, 20 mM Na2EDTA, 1.4 M NaCl, and 1% polyvinylpyrolidine), 17 µl of
RNase A, and 17 µl of Proteinase K. Samples were homogenized using a bead mill for
three minutes twice at maximum speed, and incubated at 60°C for one hour. The mixture
was transferred to a NucleoSpin filter column and centrifuged for five minutes at
11,000 x g. The flow through was transferred to a second NucleoSpin filter column
and mixed with 850 µl binding buffer (550 µl PC), and centrifuged for one minute at
11,000 x g. The filter was washed with 400 µl of wash buffer 1, and centrifuged for one
minute at 11,000 x g. The filter was washed a second and third time with 700 µl and 200
µl of PW2, respectively. The filter was dried by centrifugation for two minutes at 13,000
x g. DNA was eluted with 75 µl of 70°C elution buffer (PE), incubated at room
temperature for five minutes, and centrifuged at 8,000 x g for one minute. DNA
concentration (ng/µl) was determined using a NanoDrop 1000 spectrophotometer
(Thermo Scientific, Waltham, MA).
Polymerase Chain Reaction (PCR) and Gel Electrophoresis
The ITS region was amplified for the extracted DNA using a nonspecific forward
primer: 5’-CTTGGTCATTTAGAGGAAGTAA-3’ (Gardes and Bruns, 1993) and a
nonspecific reverse primer: 5’-TCCTCCGCTTATTGATATGC-3’ (White et al. 1990).
Fungal DNA amplification was carried out using an Eppendorff Mastercycler with the
following settings: an initial hot start at 98°C for two minutes (DNA template only),
melting at 95°C for 45 seconds, annealing at 52°C for 45 seconds, and extension at 72°C
for two minutes, and final extension at 72°C for 10 minutes for 35 cycles. After the initial
hot start, a master mix containing 10 mM reaction buffer, 25 mM MgCl, 10 mM
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deoxynucleotide triphosphates (dNTPs), 10 mg/ml Bovine Serum Albumin (BSA),
deionized water, and 5 units/µl Taq polymerase was added to each sample.
An 8 µl sample of amplified DNA was added to 2 µl of loading dye (50 mM
EDTA, 30% glycerol, 0.25% bromophenol blue, 0.25% xylene cyanol) and loaded into a
2% agarose gel to assess successful amplification of the ITS region.
PCR Clean Up
Successfully amplified PCR products were filtered with the NucleoSpin Extract
II (Machery-Nagel) kit to remove residual PCR reagents. Sample products were loaded
onto a filter column and centrifuged for one minute at 11,000 x g. The membrane was
washed with 600 µl of NT3 and centrifuged for one minute at 11,000 x g. The filter was
dried by centrifugation for two minutes at 11,000 x g. Purified PCR products were eluted
with 20 µl of 70°C elution buffer (NE) incubated at room temperature for five minutes,
and centrifuged at 11,000 x g for one minute. Samples were then visualized on a 2%
agarose gel and base pair size was determined.
Sequence Analysis
Up to 10 µl of purified PCR products (33 ng – 64 ng) with 8 µl of DTCS Quick
Start Master Mix (Beckman Coulter) and 2 µl forward primer and reverse primer,
respectively, were prepped for sequencing using an Eppendorff Mastercycler with the
following settings: 96°C for 20 seconds, 50°C for 20 seconds, and 60°C for four minutes,
for 30 cycles. Immediately following the amplification reaction, 5 µl of stop solution (2
µl of 3 M Sodium Acetate, pH 5.2, 2 µl of 100 mM Na2EDTA, pH 8, 1 µl of 20 mg/mL
glycogen) was added to each reaction tube. A 60 µl aliquot of cold 65% ethanol was also
added and the samples were centrifuged for 15 minutes at 4°C and 14,000 x g. The
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supernatant was removed and the pellet was washed twice with 200 µl of cold 70%
ethanol and centrifuged for 2 minutes at 4°C and 14,000 x g. After the second wash, the
samples were air-dried and resuspended in 40 µl of sample loading solution. Samples
were loaded into a sequencing plate, capped with one drop of mineral oil, and sequenced
with CEQ 8000 Genetic Analysis System (Beckman Coulter). Sequences were
processed using the CEQ sequencing analysis software and MegAlign (Lasergene) was
used to determine match identities.
Preliminary Study Two: Oxalate Screening Analysis
Fungal Isolates
Isolates used for this analysis include: Baxter-31, HHB-6386-SP, FP-103272-T,
FP-105309-R, FP-105780-SP, FP-90848-T, L-12451-SP, L-7878-SP, L-9318-SP, L9414-SP, L-11659-SP, L-12617-SP, MJL-630-SP, RLG-7629-SP, and TFFH 294. All
isolates were maintained on 2% malt agar (BD, Fisher Scientific, Pittsburg, PA) media
plates.
Test Wafer Preparation and Preservative Treatments
Two sets of southern yellow pine (SYP) wafers measuring 24 mm x 18 mm x 5
mm (t x r x l) were vacuum treated with micronized copper quaternary ammonia
compound (MCQ) and amine copper (CA), respectively. SYP test wafers were
autoclaved for 20 minutes at 16 psi at 122°C prior to exposure to prevent contamination.
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Decay Test
Decay Chamber Setup
A modified version of the AWPA soil-block test (Standard E22-09) was used for
this study (AWPA 2010). Decay chambers consisted of round plastic containers 110 mm
in diameter and 80 mm in depth with matching lids. The lids were punctured and a
cotton plug was inserted to facilitate gas exchange while maintaining sterile conditions.
Chambers were filled with 75 mL sterile deionized water initially followed by 150 g of
soil (Dorman Lake test site), which was sifted to remove unwanted debris prior to use.
Two SYP feeder strips measuring 65 mm x 20 mm x 3 mm (t x r x l) were placed directly
on the soil surface in each container with approximately a 1 cm gap between them.
Chambers were sealed and autoclaved for sterility for 40 minutes at 16 psi and 122°C.
After sterilization, chambers were placed under a laminar flow hood and allowed to cool
before inoculation.
Inoculation of Feeder Strips and Incubation
Sterile containers were inoculated aseptically with approximately 6 mm plugs of
actively growing mycelia. Four mycelia plugs from each of the 15 isolates were placed
in each container adjacent to the SYP feeder strips and in contact with the soil surface,
respectively. Containers were sealed and incubated at 26.7°C for 2 weeks to allow initial
colonization of the feeder strips.
After the 2-week colonization period, two MCQ and two CA treated SYP test
wafers were placed directly on top of the colonized SYP feeder strips per one container
(Figure 2.1). Ten milliliters of sterile deionized water was added to each container prior
to being sealed. All containers were incubated at 26.7°C for 4 weeks.
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Figure 2.1

Decay chamber set-up including feeder strips and test wafers exposed to
isolate, L-11659-SP.
Sample Preparation

SYP test wafers were removed from incubation at weeks 2 and 4, and were gently
brushed free of surface mycelia. Each wafer was placed separately in a 50 mL disposable
sterile centrifuge tubes (Fisherbrand), three milliliters of 0.1 M phosphate buffer pH 7.0
(62 mL 0.1 M Na2HPO4 and 38 mL 0.1 M KH2PO4) was added, and the tubes were
shaken for 2 hours. After agitation, one milliliter of liquid was stored at -20°C for
oxalate and protein analysis.
Oxalate Assay
Ten µl of sample solution and oxalate standards were placed in 96-well
polystyrene microplates (Costar, Corning, NY), respectively. Two-hundred µl of
Reagent A (oxalate oxidase reagent) and 20 µl Reagent B (3-methyl-2-benzothiazoline
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hydrazone reagent) were added to each well (Trinity Biotech Co., Wicklow, Ireland).
The 96-well plate was gently shaken and incubated at room temperature for five minutes.
Concentration (mg/ml) was measured spectrophotometrically at 560 nm using an Epoch
Microplate Spectrophotometer (BioTek, Winooski, VT).
Protein Assay
Oxalate concentration was normalized based on total protein concentration
according to the Bradford Protein Assay protocol. The dye reagent (Bio-Rad
Laboratories) was diluted with four parts deionized water and 200 µl was added to 10 µl
sample solution in the 96-well microplate. The plate was incubated at room temperature
for five minutes before absorbance (concentration (mg/ml)) was measured at 595 nm.
Evaluating the Role of Oxalate: Enzyme Analysis Results
Fungal Isolates
Isolates used for this analysis include: FP-90848-T, L-9414-SP, L-11659-SP, and
TFFH 294. All isolates were maintained on 2% Malt agar (BD, Fisher Scientific,
Pittsburg, PA) media plates.
Test Wafer Preparation and Preservative Treatments
Test wafers (SYP) measuring 70 mm x 22 mm x 4 mm (t x r x l) were vacuum
treated with 1.2% ammoniacal copper citrate for 40 minutes at 172 kPa. Untreated
wafers served as controls. All SYP test wafers were autoclaved for 20 minutes at 16 psi
at 122°C prior to exposure to prevent contamination.
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Decay Test
Decay Chamber Setup
The same modified version of the AWPA soil-block test (Standard E22-09) used
in Preliminary Study Two was also used for this study (AWPA 2010).
Inoculation of Feeder Strips and Incubation
Sterile containers were inoculated aseptically with approximately 6mm plugs of
actively growing mycelia. Six mycelia plugs from the 4 isolates were placed in each
container adjacent to the SYP feeder strips and in contact with the soil surface,
respectively. Containers were sealed and incubated at 26.7°C for 2 weeks to allow initial
colonization of the feeder strips.
After the 2-week colonization period, two SYP test wafers (copper citrate and
untreated, respectively) were placed directly on top of the colonized SYP feeder strips per
container (Figure 2.2). Ten milliliters of sterile deionized water was added to each
container prior to being sealed. All containers were incubated at 26.7°C for 8 weeks.
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Figure 2.2

Test wafers exposed to isolate, L-9414-SP, in an AWPA standard decay
chamber.

Sample Preparation
Untreated and 1.2% copper citrate treated SYP wafers exposed to the four isolates
were harvested at weeks 2, 4, 6, and 8. Blocks were rasped into sawdust-like material
and approximately 0.2 g of sawdust was placed into 2 mL tubes containing two 5 mm
glass beads. The 2 mL tubes were dropped in liquid nitrogen to flash freeze any
enzymatic activity the samples contained at the time and stored at -80°C until processed.
Oxalate Assay
To determine oxalate concentration, 1.5 mL of cold 0.1 M phosphate buffer was
added to each sample and homogenized for three minutes by a bead mill. After
centrifuging to remove unwanted debris, the crude homogenate was placed directly on ice
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for processing. Concentration was analyzed spectrophotometrically by the Biotek Epoch
96-well plate reader at 560 nm using oxalate reagents from Trinity Biotech.
Enzyme Assays
To determine enzyme activity, one sample of sawdust was removed from the
freezer and placed directly on ice. A 1.5 mL aliquot of cold buffer, specific to the assay
protocol, was added to each tube and homogenized for three minutes by a bead mill, and
immediately returned to ice. Tubes were centrifuged for two and a half minutes at 12,000
RCF at 4°C, the supernatant was placed into a clean 1.5 mL tube, and tubes were recentrifuged to remove any residual debris. The crude homogenate was aliquoted into
0.5 mL tubes and placed directly on ice for processing. Extras were stored at -80°C.
Fumarase, glyoxylate dehydrogenase, isocitrate lyase, malate synthase, and
oxaloacetase were assayed with an Epoch Microplate Spectrophotometer according to the
specific wavelength for each enzyme. Assay protocols were modified for 96-well plate
volumes, and samples were measured in triplicate. To determine activity, absorbance
values were measured every 15 seconds for a 2 minute period and the change in
absorbance/minute (ΔA/min) was calculated from these values. Varying amounts of
enzyme filtrate (crude homogenate) were used for each sample. Concentration was
normalized based on total protein values. Total protein (mg), total units (IU), and
specific activity (IU/mg) were calculated for test samples showing detectable activity.
Fumarase Assay
Fumarase activity was determined based on the protocol outlined by Bergmeyer et
al. (Sigma-Aldrich 1998). Potassium phosphate buffer (100 mM pH 7.6) was added to
each sawdust sample before homogenization. Total assay volume (200 µl) contained
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final concentrations of 50 mM L-malic acid and enzyme filtrate. ΔA/min was measured
at 240 nm at 25°C. Enzyme activity was indicated by an increase in ΔA/min over time.
Glyoxylate Dehydrogenase Assay
Glyoxylate dehydrogenase activity was determined based on the protocol outlined
by Tokimatsu et al. (1998). Potassium phosphate buffer (35 mM pH 8.0) was added to
each sawdust sample before homogenization. Total assay volume (200 µl) contained
final concentrations of 32 mM glyoxylate, 0.16 mM cytochrome c, and enzyme filtrate.
ΔA/min was measured at 550 nm at 30°C. Enzyme activity was indicated by an increase
in ΔA/min over time.
Isocitrate Lyase Assay
Isocitrate lyase activity was determined based on the protocol outlined by Chell et
al. (Sigma-Aldrich 1996a). Imidazole buffer (50 mM pH 6.8) was added to each sawdust
sample before homogenization. Total assay volume (200 µl) contained final
concentrations of 50 mM MgCl2, 10 mM EDTA, 40 mM phenylhydrazine HCl, 10 mM
DL-isocitrate,

and enzyme filtrate. ΔA/min was measured at 324 nm at 30°C. Enzyme

activity was indicated by an increase in ΔA/min over time.
Malate Synthase Assay
Malate synthase activity was determined based on the protocol outlined by
Silverstein and Chell et al. (Sigma-Aldrich, 1996b). Imidazole buffer (50 mM pH 8.0)
was added to each sawdust sample before homogenization. Total assay volume (200 µl)
contained final concentrations of 100 mM MgCl2, 2.5 mM acetyl CoA, 10 mM glyoxylic
acid, 2 mM DTNB (prepared in 95% ethanol), and enzyme filtrate. ΔA/min was
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measured at 240 nm at 30°C. Enzyme activity was indicated by an increase in ΔA/min
over time.
Oxaloacetase Assay
Oxaloacetase activity was determined based on the protocol outlined by
Akamatsu et al. (1992). Potassium phosphate buffer (0.1 M pH 7.6) was added to each
sawdust sample before homogenization. Total assay volume (200 µl) contained final
concentrations of 0.2 M imidazole buffer, 1 mM oxaloacetic acid, and enzyme filtrate.
ΔA/min was measured at 255 nm at 30°C. Enzyme activity was indicated by a decrease
in ΔA/min over time.
Protein Assay
Oxalate and enzyme concentrations were normalized based on total protein
concentration according to the Bradford Protein Assay protocol as previously described.
Evaluating the Role of Oxalate: Gene Expression Results
RNA Extraction
RNA was isolated using the Ambion RNAqueous Kit (Ambion, Austin, TX)
with an added DNase I (Promega, Madison, WI) digestion step to remove unwanted
genomic DNA contaminants. For each test sample, five tubes containing 0.2 g sawdust
were placed on ice and each received 1 mL denaturation buffer. Tubes were
homogenized using a bead mill for three minutes, incubated on ice for three minutes, then
homogenized again for three minutes. After homogenization, tubes were centrifuged at
10,000 RCF for two minutes and the supernatant was transferred into new 2.0 mL tubes
free of debris. The clarified supernatant was pooled and centrifuged again to remove any
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residual debris. An equal volume of 64% ethanol was added to each sample and mixed
by pipetting. A 700 µl aliquot of the supernatant/ethanol mixture was added to a filter
column and centrifuged at 10,000 RCF for 30 seconds. The filtrate was discarded and
this step was repeated until all of the supernatant/ethanol mixture was passed through the
filter. Following this step, 500 µl of Wash Solution #1 was added to the filter column
and centrifuged at 10,000 RCF for 30 seconds and the flow-through was discarded. In a
new tube, DNase I digestion was prepared by adding 40 µl DNase-free water, 5 µl DNase
I 10x Buffer, and 5 µl DNase I enzyme. The digestion mixture was gently mixed and 50
µl was added directly to each filter and incubated at room temperature for 15 minutes.
After incubation, the filter was washed twice with 500 µl of Wash Solution #2/3 and
centrifuged at 10,000 RCF for 30 seconds, discarding the flow-through. The filter was
centrifuged again at 10,000 RCF for 2 minutes to dry the membrane and remove any
residual ethanol. The filter was placed in a new collection tube and RNA was eluted by
two aliquots of 40 µl and 10 µl of 70°C Elution Solution. The filters were incubated at
room temperature for one minute before being centrifuged at 10,000 RCF for one minute.
Following elution, RNA was kept on ice at all times. RNA was quantified by a
NanoDrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA), and quality was
determined by Experion chip electrophoresis (RNA StdSens Analysis Kit, Bio-Rad;
Hercules, CA). All RNA was stored at -80°C.
cDNA Synthesis
Bio-Rad iQ iScript
RNA was synthesized to first strand cDNA by the iScript cDNA Synthesis Kit
(Bio-Rad, Hercules, CA). For each sample, 4 µl of 5x iScript reaction mix and 15 µl of
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RNA template (0.20 µg) and nuclease-free water were added to a 0.2 mL tube and heated
for 2 minutes at 70°C and immediately returned to ice. One µl of iScript reverse
transcriptase was added to each reaction and the protocol was performed using an
Eppendorff Mastercycler with the following settings: incubation at 25°C for 5 minutes,
incubation at 42°C for 30 minutes, and incubation at 85°C for 5 minutes.
Invitrogen SuperScript II Reverse Transcriptase
RNA was also synthesized to first strand cDNA by the Invitrogen SuperScript
II Reverse Transcriptase Kit (Carlsbad, CA). For each sample, 1 µl of Oligo(dT)12-18
primer, 1 µl of 10 mM dNTP mix, and 10 µl of RNA template (1 µg) and nuclease-free
water were added to a 0.2 mL tube and heated for 5 minutes at 65°C then immediately
returned to ice. Four µl of 5x First-Strand Buffer, 2 µl of 0.1 M DTT, and 1 µl
SUPERaseIn was added to the reaction mix and incubated at 25°C for 10 minutes.
Following incubation, 1 µl of SuperScript II RT was added to each reaction and mixed
by pipetting gently up and down. cDNA synthesis was carried out using an Eppendorff
Mastercycler with the following settings: incubation at 42°C for 90 minutes and
incubation at 85°C for 5 minutes. Non-template controls (no RNA template added to the
reaction mixture) were also included.
Reverse transcriptase free controls were prepared by adding 1 µl of Oligo(dT)12-18
primer, 1 µl of 10 mM dNTP mix, and 10 µl of RNA template (1 µg) and nuclease-free
water to a 0.2 mL tube and heated for 5 minutes at 65°C then immediately returned to ice.
Four µl of 5x First-Strand Buffer, 2 µl of 0.1 M DTT, and 1 µl SUPERaseIn was added
to the reaction mix and incubated at 25°C for 10 minutes. cDNA synthesis was carried
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out using an Eppendorff Mastercycler with the following settings: incubation at 42°C
for 90 minutes and incubation at 85°C for 5 minutes.
Primer Design
Expression levels of six specific genes were examined for the copper citrate and
untreated test samples across all time points using real-time qPCR. Gene-specific
primers were designed utilizing gene and coding (CDS) sequences of F. radiculosa
TFFH 294 obtained from Dr. Juliet Tang. CDS sequences for isocitrate lyase (ICL),
glyoxylate dehydrogenase (GLOXDH), citrate synthase (CS), succinate/fumarate
antiporter (ANTI), and the copper resistance-associated ATPase pump (ATPase) were
matched against gene sequences for the respective genes. Target regions spanning at
least one intron were determined by Lasergene MegAlign (DNASTAR, Madison, WI).
Forward and reverse primer pairs were designed for these target regions to have at least
50% GC content, no 3’ complementarity, and uniquely specific for the desired region.
Sequences used for real-time qPCR are listed in Table 2.1. Actin (HK) was used as the
housekeeping gene.
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Table 2.1
Target
Gene

Target gene, nucleotide sequence, and reference gene accession number for
all oligonucleotide primers used for gene expression.
Primer Sequence

Accession Number

HK

Forward
Reverse

5'-GTGATGGTTGGTATGGGTCAGAAGG
5'-GAAGCTCGTTGTAGAAAGTGTGATGC

XP_003026150.1

ICL

Forward
Reverse

5'-CAGTACTGCATCCAGCACGAACGAGC
5'-CGTGACTCTGCTTGCTTGCGGTCGTG

BAD93181.1

Forward

5'-CGATGCGATCACGACAAACCTGCGCC
5'-CGAGGAACTTCTGCCGCCGCTTCTC

BAH29964.1

CS

Forward
Reverse

5'-CATCCTATGAGCCAATTCAGTTTGGC
5'-CCATGCAGTCTTCGAATACCGGCTTC

EGN99006.1

ANTI

Forward
Reverse

5'-CAAGGGATGGCTAGCAGACAAGGAG
5'-GCCGAATCTTCACAACCTCCATGGGC

EGO00768.1

ATPase

Forward
Reverse

5'-GCGCTGCGTCGTGGCTATGGTTGGCG
5'-CCGATACAAGGATGAACGCGGCGCTG

XP_002473512.1

GLOXDH Reverse

Primer pairs were screened by conventional PCR to insure correct regions were
amplified. Only a small sample set (all four isolates, one time point, one treatment) was
screened to conserve reagents. Sample reactions contained 10 µl of iQ Supermix, 0.5
µl forward primer, 0.5 µl reverse primer, 8 µl nuclease-free water, and 1 µl cDNA
template (Bio-Rad, Hercules, CA). The reaction protocol included an initial denaturation
at 95°C for 3 minutes, followed by 40 cycles of a 15 second 95°C denaturation, 30
second annealing at 65°C, 30 second 72°C extension, and a final extension at 72°C for 5
minutes. Both non-template controls (NTC) and RT-free controls were also included. A
2 µl sample of amplified product and 6 µl running buffer was added to 2 µl of loading
dye (50 mM EDTA, 30% glycerol, 0.25% bromophenol blue, 0.25% xylene cyanol) and
loaded into a 2% agarose gel to visualize successful amplification of the target regions.
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Real-Time qPCR
To determine gene expression, Reverse Transcriptase Quantitative Polymerase
Chain Reaction (RT-qPCR) was monitored in real time for the six genes in question. RTqPCR reactions were carried out in an iCycler iQ 96 well PCR plates with Microseal
‘B’ Film using an iQ 5 Real-Time PCR Detection System (Bio-Rad, Hercules, CA).
Two genes of interest were performed on one plate and all samples were measured in
triplicate. The 20 µl reactions contained 10 µl 2x iQ SYBR Green Supermix (BioRad, Hercules, CA), 8 µl sterile molecular grade water, 0.5µl of both forward and reverse
primers (10 µM), and 1 µl cDNA template. The reaction protocol included an initial
denaturation at 95°C for 3 minutes, followed by 40 cycles of a 15 second 95°C
denaturation, 30 second annealing at 65°C, and a 30 second 72°C extension. A melt
curve analysis of the resulting PCR product was performed immediately following the
amplification and consisted of a 1 minute incubation at 95°C followed by a 1 minute
annealing at 55°C prior to 81 cycles of 10 seconds with temperatures increase 0.5°C each
cycle. Following amplification, threshold (CT) values were calculated and normalized
against expression data for the HK gene using the 2-∆∆CT method.
Evaluating the Role of Oxalate: The Effects of Copper Results
Fungal Isolates
Isolates used for this analysis include: FP-90848-T, L-9414-SP, L-11659-SP, and
TFFH 294. All isolates were maintained on 2% Malt agar (BD, Fisher Scientific,
Pittsburg, PA) media plates.
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Test Block Preparation and Preservative Treatments
Test blocks (SYP) measuring 10 mm3 were vacuum treated with 1.2%
ammoniacal copper citrate. Untreated blocks served as controls. Both treated and
untreated blocks were conditioned at 27°C and 70% relative humidity (RH) for 2 weeks.
Following conditioning, all blocks were steam-sterilized for 20 minutes at at 122°C prior
to exposure to prevent contamination.
Decay Test
Decay Chamber Setup
A modified version of the AWPA soil-block test (Standard E10-09) was used for
this study (AWPA 2009). Decay chambers consisted of 16 oz. glass culture bottles with
metal screw cap lids. The glass bottles were filled with soil (according to Standard E1009) and an SYP feeder strip measuring 34 mm x 28 mm x 3 mm. Bottles were capped
and autoclaved for sterility for 40 minutes at 16 psi and 122°C. After sterilization,
chambers were placed under a laminar flow hood and allowed to cool before inoculation.
Inoculation of Feeder Strips and Incubation
Sterile bottles were inoculated aseptically with approximately 6 mm plugs of
actively growing mycelia. Four mycelia plugs from each isolate were placed in each jar
adjacent to the SYP feeder strips and in contact with the soil surface, respectively.
Containers were capped and incubated at 27°C and 70% RH for 2 weeks to allow initial
colonization of the feeder strips.
After the 2-week colonization period, five variations of copper citrate – treated
test blocks were placed directly on top of the colonized SYP feeder strips to assess the
difference in oxalate production when exposed to the four isolates. Variation 1 included
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untreated SYP blocks to serve as primary controls. Variation 2 included 1.2%
ammoniacal copper citrate blocks to serve as the secondary controls. Variation 3
included 1.2% ammoniacal copper citrate blocks placed directly on top of untreated
blocks, which were in contact with the feeder strips. Variation 4 included 100 µl of 1.2%
ammoniacal copper citrate added directly on top of untreated blocks. Variation 5
included untreated blocks that were adjacent to in direct contact with 1.2% ammoniacal
copper citrate blocks; the copper treated blocks were introduced every two weeks (Figure
2.3). For variations 3, 4, and 5 untreated blocks were assayed for oxalate production. All
containers were incubated at 27°C and 70% RH for 8 weeks; with the exception of
Variation 5, which only ran for 6 weeks.

Figure 2.3

Variations on copper citrate (CC) – treated test blocks exposed to F.
radiculosa. Bottle 1: untreated SYP; Bottle 2: CC treated SYP; Bottle 3:
CC treated SYP on top of untreated SYP; Bottle 4: liquid CC on top of
untreated SYP; Bottle 5: CC treated SYP adjacent to and in direct contact
with untreated SYP.
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Sample Preparation
Six SYP test blocks were removed from test bottles after 2, 4, 6, and 8 weeks of
incubation and were gently brushed free of surface mycelia. Blocks that were tested for
oxalate production were untreated blocks (variation 1), 1.2% ammoniacal copper citrate
blocks (variation 2), untreated blocks (variation 3), 100 µl of 1.2% ammoniacal copper
citrate added to untreated blocks (variation 4), and untreated blocks exposed to 1.2%
ammoniacal copper citrate blocks every two weeks. Appropriate blocks were placed
separately in a 50 mL disposable sterile centrifuge tubes, three milliliters of 0.1 M
phosphate buffer pH 7.0 was added, and the tubes were shaken for 2 hours. After
agitation, one milliliter of liquid was removed and stored at -20°C for oxalate analysis.
Oxalate Assay
Concentration was analyzed (triplicate) spectrophotometrically by the Biotek
Epoch 96-well plate reader at 560 nm using oxalate reagents from Trinity Biotech as
described previously.
Weight Loss
Initial weights of all test blocks were recorded prior to inoculation. After oxalate
concentration was determined, exposed test blocks were oven-dried overnight at 60°C
and weights were recorded the following day. Test blocks were reconditioned to initial
conditions (27°C 70% RH) for two weeks prior to reweighing. Weight loss (%) was
calculated to determine the decay capacity of the samples with respect to treatment and
time.
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CHAPTER III
RESULTS AND DISCUSSION
Preliminary Study One: Sequencing Analysis Results
Sequence Analysis
The purpose of preliminary study one was to evaluate the differences, if any, by
sequencing the ITS region of the fifteen F. radiculosa isolates. Pure culture tissue
samples were successful in generating pure DNA (A260/280 = 1.8) for all fifteen isolates.
PCR amplification was successful and showed one major band for each of the fifteen
isolates on the 2% agarose gel. The ITS region was sequenced for each isolate and the
sequences were aligned by Clustal W in MegAlign (Lasergene®). Sequence distances
(percent identity and divergence) were calculated for the fifteen different isolates (Figure
3.1). To the right of the black diagonal line in Figure 3.1 are percent identities of the
fifteen sequences aligned against each other. To the left of the black diagonal line in
Figure 3.1 is the divergence of the fifteen sequences aligned against each other. The
evolutionary relationships between the fifteen isolates are represented in Figure 3.2.
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Figure 3.1

Sequence distances based on percent identity and divergence of the fifteen
F. radiculosa isolates.

Figure 3.2

Phylogenetic tree of F. radiculosa isolates based on sequence distances
(nucleotide substitutions).

The phylogenetic analysis of the fifteen isolates showed some variability in the
ITS region. Connection at the same branch indicated two isolates were closely related in
comparison to the other isolates (Figure 3.2). Overall, L-7878-SP had the highest
difference in nucleotide sequences (Figure 3.2) when compared to the other fourteen
isolates. The lowest percent identity match (Figure 3.1) was between FP-105780-SP and
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L-7878-SP. NCBI nucleotide blast indicated that this isolate was not Fibroporia
radiculosa.
Preliminary Study Two: Oxalate Screening Results
The purpose of preliminary study two was to determine the variation of oxalate
production for the fifteen F. radiculosa isolates. All isolates were exposed to amine
copper (CA) and micronized copper quaternary (MCQ) treated SYP wafers for a four
week period. Oxalate and protein production was analyzed at two and four weeks for all
samples. Concentration values depicted in the figures are the average of four biological
replicates. Following the evaluation, TFFH 294 and three other isolates were chosen for
enzyme analysis and gene expression based on growth capability and oxalate production.
Oxalate Assay
Results clearly indicate all isolates have the ability to produce oxalate when
exposed to CA and MCQ treated SYP wafers at 2 and 4 weeks. Figure 3.3 shows the
variation of oxalate concentration (mg/mL) at weeks 2 (dark) and 4 (light) for CA (blue)
and MCQ (green) treated SYP wafers with respect to each isolate. Overall, highest
oxalate concentration was seen in FP-103272-T at week 2 on CA treated wood (1.185
mg/mL) and in FP-105309-R at week 2 on MCQ treated wood (1.050 mg/mL). At week
4 the highest oxalate concentration was seen in FP-90848-T for both CA and MCQ
treated wood (0.933 mg/ml and 0.681 mg/mL, respectively). The lowest oxalate
concentration for both time points was seen in L-7878-SP for both CA and MCQ treated
wood. With the exception of L-7878-SP, isolates produced similar amounts of oxalate
for the two treatments and time points. It is possible that the lack of high oxalate
production by L-7878-SP was an indication that this organism is not copper tolerant.
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ANOVA analysis was performed to determine significant difference between isolates. At
the 0.05 level (Tukey’s mean separation), it was found that the isolates (excluding L7878-SP) were not significantly different from each other at both time points.

Figure 3.3

Oxalate concentration values (mg/mL) of fifteen Fibroporia radiculosa
isolates exposed to amine copper (CA) and micronized copper quaternary
(MCQ) test wafers for 2 and 4 weeks.

To degrade the wood cell wall components efficiently, the presence of a low pH
environment appears essential. Theoretically, oxalate aids in developing the pH gradient
between the fungal hyphae and the wood cell wall by precipitating calcium-oxalate
crystals. This precipitation of oxalate crystals functions to drive the pH of the
environment lower to allow degradation by cellulolytic enzymes (Goodell 2003; Hastrup
et al. 2006). In the presence of copper, high oxalate accumulation initiates the
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precipitation of copper-oxalate crystals, which render the copper ion inert (DeGroot and
Woodward 1999; Green and Clausen 2003). The formation of copper-oxalate crystals is
stimulated by a low pH environment (Green and Clausen 2005). As expected, oxalate is
present in the initial stages of decay; however, concentration fluctuates with respect to
isolate (Figure 3.3). This fluctuation could be attributed to the organism’s ability to adapt
to the presence of copper within the respective test wafer or an indication of inhibition by
the amine and quaternary components in the treatments. It is possible that some isolates
take longer than others to acclimate to their environment in the presence of CA and/or
MCQ treated wood (FP-90848-T week 4). The fluctuation could also be due to the
individual isolate’s ability to synthesize oxalate in the presence of the two different
copper treatments. For example, FP-103272-T produced much higher concentrations of
oxalate when exposed to CA at week 2 than when exposed to MCQ at week 2 (Figure
3.3). The organisms’ differing capability to grow in the presence of a co – biocide most
likely accounts for the differences in oxalate production between the fifteen isolates.
Protein Assay
Figure 3.4 shows the variation of protein concentration (mg/mL) at weeks 2
(dark) and 4 (light) for CA (blue) and MCQ (green) treated SYP wafers with respect to
the isolate. Overall, highest protein concentration was observed in L-9318-SP for both
CA and MCQ treated wood at week 4. Like oxalate production, the isolates produced
similar amounts of protein for the two treatments and time points. Again, L-7878-SP
produced very low protein concentrations for both treatments and time points, which are
most likely attributed to its poor growth on CA and MCQ, treated wood. ANOVA
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analysis (P = 0.05) indicated no significant difference between isolates, excluding L7878-SP, with respect to protein production.

Figure 3.4

Protein concentration values (mg/mL) of fifteen Fibroporia radiculosa
isolates exposed to amine copper (CA) and micronized copper quaternary
(MCQ) test wafers for 2 and 4 weeks.
Protein concentration is a reflection of the active growth of a particular

test fungus. An elevation in protein concentration can be directly correlated to an
increase in the growth of the organism at a given time point. It can also be related to how
well the organism can adapt to a particular substrate. Because protein concentration is a
reflection of active growth, it can be assumed that the protein concentration might also be
a reflection of how well the organism produces metabolites like oxalate. For this study,
oxalate concentration might be directly compared between isolates by evaluating the
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protein concentration in the test samples. If an isolate produced low protein but high
oxalate, the actual oxalate production for that particular isolate would be much higher in
comparison to the other isolates. For example, FP-90848-T produced very low protein
concentration for CA and MCQ treated wood at week 4 when compared to the other
isolates (Figure 3.4). This low protein production actually means that FP-90848-T
produced preferentially higher oxalate than documented (Figure 3.3), as well as much
higher oxalate in comparison to the other isolates. The same holds true for high protein
production and low oxalate production. For example, Baxter-31 produced relatively high
protein for CA and MCQ treated wood at week 2 in comparison to the other isolates
(Figure 3.4). This high protein actually means that Baxter-31 produced even lower
oxalate values than documented (Figure 3.3). In reality, Baxter-31 produced very low
oxalate at week 2 and FP-90848-T produced very high oxalate at week 4 in comparison
to the other isolates. Measuring protein is extremely important in determining and
understanding certain comparisons between isolates, treatments, and time.
Due to the lack of significant variation in oxalate and protein production between
isolates, excluding L-7878-SP, other factors were examined before determining which
three isolates (TFFH 294 automatically chosen) would be used for enzyme analysis and
gene expression. ANOVA analysis indicated there was significant variation between CA
and MCQ treated samples with respect to oxalate production, as well as significant
variation between the two time points with respect to oxalate production. Although
statistically there were no differences between isolates there were differences in trends
between some isolates. Based on the results of this study, L-11659-SP, FP-90848-T, L9414-SP, and TFFH 294 were used to determine enzyme activity and gene expression in
relation to oxalate production.
52

Evaluating the Role of Oxalate: Enzyme Analysis Results
The purpose of this study was to evaluate potential factors involved in the
production of oxalate within L-11659-SP, FP-98048-T, TFFH 294, and L-9414-SP when
undergoing decay of 1.2% copper citrate (CC) treated and untreated (UN) SYP wafers.
Test samples were analyzed for oxalate and enzyme activity for five enzymes thought to
be involved in the production of oxalate. In order to determine the specific activity of
each enzyme, protein concentration was also determined. Concentration values
illustrated in the next series of figures are the average of four biological replicates. Based
on oxalate production and enzyme activity results, only certain enzymes from this study
were evaluated for the differential expression of genes.
Oxalate Assay
Overall, oxalate production reached its highest level at week 6 for all isolates
when exposed both CC and UN treated wood. Lowest production of oxalate was at week
2 for all isolates exposed to both CC and UN treated wood. Figure 3.5 shows the
variation of oxalate concentration (mg/mL) for each time point for each of the four
isolates for both CC and UN treatments. Dark colors (green, blue, red, and purple)
represent CC treatment and light colors represent UN treatment.
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Figure 3.5

Oxalate concentration values (mg/mL) of L-11659-SP (green), FP-90848-T
(blue), TFFH 294 (red), and L-9414-SP (purple) exposed to copper citrate
(CC) and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

ANOVA analysis (P = 0.05) indicated a significant difference between all four
time points with respect to oxalate production. Table 3.1 details the variation between
the time points; a difference of 0.1457 between mean values signifies the minimum
significant difference.
Table 3.1

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to time. A, B, C, and D are all significantly different from each
other.
Tukey’s
Grouping
A
B
C
D

Time

Mean

6 weeks
8 weeks
4 weeks
2 weeks

0.78656
0.61895
0.38863
0.22376
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The highest overall producer of oxalate was FP-90848-T. Figure 3.6 shows the
variation of oxalate concentration (mg/mL) for each isolate exposed to both CC and UN
treatments for the four time points. Dark colors (green, blue, red, and purple) represent
CC treatment and light colors represent UN treatment.

Figure 3.6

Oxalate concentration values (mg/mL) for 2 weeks (green), 4 weeks (blue),
6 weeks (red) and 8 weeks (purple) for isolates L-11659-SP, FP-90848-T,
TFFH 294, and L-9414-SP exposed to copper citrate (CC) and untreated
(UN) test wafers.

ANOVA analysis (P = 0.05) indicated significantly more oxalate was produced
by FP-90848-T compared to L-11659-SP and TFFH 294; however, there was not a
significant difference between FP-90848-T and L-9414-SP. L-11659-SP, TFFH 294, and
L-9414-SP were not significantly different from each other. Table 3.2 details the
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variation between isolates with respect to oxalate production; a difference of 0.1449
between mean values signifies the minimum significant difference.
Table 3.2

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to isolate. A is significantly different than B.
Tukey’s
Grouping
A
B
A
B
B

Isolate

Mean

FP-90848-T
L-9414-SP
L-11659-SP
TFFH 294

0.78656
0.61895
0.38863
0.22376

Figure 3.7 shows CC treated wood facilitates the production of higher oxalate
concentration (mg/mL) values overall. TFFH 294 at week 6 exposed to CC treated wood
had the overall highest oxalate concentration value (1.375 mg/mL). L-9414-SP exposed
to UN wood had higher oxalate concentration values than when exposed to CC treated
wood at weeks 2, 4, and 6.
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Figure 3.7

Oxalate concentration values (mg/mL) of copper citrate treated and
untreated test wafers exposed to L-11659-SP (green), FP-90848-T (blue),
TFFH 294 (red), and L-9414-SP (purple) for weeks 2, 4, 6, and 8.

ANOVA analysis (P = 0.05) indicated a significant difference between the two
treatments with respect to oxalate production. Table 3.3 details the variation between
treatments; a difference of 0.0779 between mean values signifies the minimum
significant difference.
Table 3.3

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to treatment. A is significantly different than B.
Tukey’s
Grouping
A
B

Treatment

Mean

Copper Citrate
Untreated

0.59463
0.40426
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Oxalate concentration produced by the four isolates exposed to both treatments
was significantly higher at week 6 (Table 3.1). FP-90848-T generated significantly
higher amounts of oxalate for both CC and UN treatments over the eight week period
(Table 3.2). TFFH 294 produced the lowest oxalate concentration when compared to the
other three isolates over the course of the study (Table 3.2). Overall, the CC treatment
stimulated significantly higher amounts of oxalate than the UN controls (Table 3.3).
Oxalate is a critical component of decay by brown-rot fungi because of its ability
to establish the organism within a particular woddy environment. Because oxalate is
crucial in allowing the organism to survive a certain environment, production should be
higher in the initial stages of decay. Overall, accumulated oxalate increased from weeks
2 through 6 and then dropped at week 8 (Figure 3.5). It is possible that these isolates are
accumulating high oxalate concentrations at week 6 because that is the time point in
which oxalate is most needed. The slight drop in oxalate production at week 8 could be
perceived as the time point to which the organism is beginning to establish itself in that
environment and no longer needs oxalate in high quantities. It should be noted that
oxalate in too high a concentration could be toxic to the fungus.
An organism will react to a particular environment as needed. In untreated wood,
the production of oxalate is still necessary to reduce the pH of the surrounding
environment. High levels of oxalate should not be required in untreated wood because
the organism does not need to overcome any extraneous chemicals. Brown-rot fungi
have evolved a mechanism to bypass the toxic effect of copper by increasing oxalate
production in the presence of a copper-rich environment. In copper-treated wood, the
organism stimulates higher amounts of oxalate in order to tie-up the copper ions
(DeGroot and Woodward 1999; Green and Clausen 2003). Overall, oxalate production is
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higher in copper citrate treated wood when compared to untreated wood (Figure 3.7;
Table 3.3). Because oxalate production in CC treated wood is higher than the UN
controls, it can be deduced that copper is in fact stimulating the production of oxalate in
these four isolates. But, the response of an individual organisms’ ability to produce
higher amounts of oxalate on CC treated wood varied with respect to time and isolate.
Biologically, all organisms are unique; therefore, it is evident that different
isolates will react differently to the same environment at a given time point.
Interestingly, only FP-90848-T and TFFH 294 showed higher oxalate production in CC
treated wood at all four time points when compared to the UN controls (Figure 3.6). At
week 2, FP-90848-T showed higher oxalate accumulation in CC treated wood when
compared to the UN controls (Figure 3.5). By week 4, FP-11659-SP showed higher
oxalate production in CC treated wood than the UN controls (Figure 3.5). In TFFH 294,
week 6 showed much higher oxalate production in CC treated wood than the UN controls
(Figure 3.5). However, L-9414-SP did not show higher oxalate production on CC treated
wood until week 8 (Figure 3.5). This could be attributed to the metabolism of the
specific isolate and its ability to initiate specific mechanisms to overcome copper in that
environment. The different responses of the four isolates could also suggest a variation
in the active growth of an individual organism in response to the copper-rich
environment.
Protein Assay
Unlike the oxalate levels, protein accumulation reached its highest cumulative
level at week 8 for all isolates when exposed to both CC and UN treated wood with the
exception of FP-90848-T (highest at week 6). Lowest protein concentration (mg/mL)
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was at week 2 for all isolates exposed to both CC and UN treated wood. Figure 3.8
shows the variation of protein concentration at each time point for all four isolates
exposed to both CC and UN treatments. Dark colors (green, blue, red, and purple)
represent CC treatment and light colors represent UN treatment.

Figure 3.8

Protein concentration values (mg/mL) of L-11659-SP (green), FP-90848-T
(blue), TFFH 294 (red), and L-9414-SP (purple) exposed to copper citrate
(CC) and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

ANOVA analysis (P = 0.05) indicated that significantly less protein was produced
at week 2 than the other three time points. Weeks 4, 6, and 8 were not significantly
different from each other. Table 3.4 details the variation between the time points; a
difference of 0.0819 between mean values signifies the minimum significant difference.
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Table 3.4

Statistical (ANOVA) analysis of significant variation in protein production
with respect to time. A is significantly different than B.
Tukey’s
Grouping
A
A
A
B

Time

Mean

6 weeks
8 weeks
4 weeks
2 weeks

0.14565
0.13539
0.10653
0.01860

The highest overall protein producer was FP-90848-T. Figure 3.9 shows the
variation of protein concentration (mg/mL) for each isolate exposed to both CC and UN
treatments for the four time points. Dark colors (green, blue, red, and purple) represent
CC treatment and light colors represent UN treatment.

Figure 3.9

Protein concentration values (mg/mL) for 2 weeks (green), 4 weeks (blue),
6 weeks (red) and 8 weeks (purple) for isolates L-11659-SP, FP-90848-T,
TFFH 294, and L-9414-SP exposed to copper citrate (CC) and untreated
(UN) test wafers.
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ANOVA analysis (P = 0.05) indicated no significant difference between isolates
with respect to protein concentration. Table 3.5 details the variation between isolates; a
difference of 0.0928 between mean values signifies the minimum significant difference.
Table 3.5

Statistical (ANOVA) analysis of significant variation in protein production
with respect to isolate.
Tukey’s
Grouping
A
A
A
A

Isolate

Mean

FP-90848-T
L-11659-SP
TFFH 294
L-9414-SP

0.14698
0.08710
0.08484
0.07677

Figure 3.10 shows protein concentration (mg/mL) values with respect to CC
treated and UN wood. For the most part, isolates on CC treated wood produced more
protein than UN samples.
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Figure 3.10

Protein concentration values (mg/mL) of copper citrate treated and
untreated test wafers exposed to L-11659-SP (green), FP-90848-T (blue),
TFFH 294 (red), and L-9414-SP (purple) for weeks 2, 4, 6, and 8.

ANOVA analysis (P = 0.05) indicated a significant difference between the two
treatments with respect to protein production. Table 3.6 details the variation between
treatments; a difference of 0.0430 between mean values signifies the minimum
significant difference.
Table 3.6

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to treatment. A is significantly different than B.
Tukey’s
Grouping
A
B

Treatment

Mean

Copper Citrate
Untreated

0.13296
0.07398
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Protein concentration was significantly lower at week 2 over the course of the
study (Table 3.4). FP-90848-T generated the highest protein concentration; however, the
concentration was not significantly different when compared to the other three isolates
(Table 3.5). It is important to note that there are differences in the amount of protein
production by each isolate in comparison to the amount of oxalate production. For
oxalate, the highest to lowest concentration by isolate is FP-90848-T, L-9414-SP, L11659-SP, and TFFH 294 (Table 3.2). However, for protein, the highest to lowest
concentration by isolate is FP-90848-T, L-11659-SP, TFFH 294, and L-9414-SP (Table
3.5). Like oxalate concentration, isolates exposed to the CC treatment generated
significantly higher protein concentration than the UN controls (Table 3.6).
Since protein concentration is directly related to active growth, it can be assumed
that higher protein production indicates better growth. Elevated protein production can
also be a reflection of the amount of work it takes to overcome an unfavorable
environment. In both CC and UN treated wood at week 2, isolates produced significantly
less protein than the other three time points (Figure 3.8; Table 3.4). This indicates that at
week 2 the fungi were just beginning to establish themselves on the wood. Theoretically,
the organism could be producing only the specific proteins which aid in helping it adapt
to the surrounding environment. The CC treatment showed significantly higher protein
production than the UN controls (Figure 3.10; Table 3.6). The increased protein
production seen in the CC treatment would suggest that these four isolates may need to
produce more proteins to bypass the copper ions and obtain nutrients for growth. It could
also indicate that detoxifying copper utilizes different metabolites, enzymes, and more
energy. Variation in the amount of oxalate produced (Table 3.2) compared to the amount
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of protein produced (Table 3.5) suggests L-11659-SP generated lower oxalate than
documented, while L-9414-SP generated higher oxalate than documented.
Enzyme Assay
The change in absorbance per minute (ΔA/min) was plotted against the measured
crude homogenate values (10µl, 25µl, 40µl, and 55µl) forming a linear relationship,
which was used to determined the slope of the best fit line (ΔA/minsample) for each test
sample. The ΔA/minsample was used to calculate total units (IU) for enzymes showing
detectable activity. Protein concentration values were used to determine total protein
(mg) for each test sample. The total units (IU) and total protein (mg) were used to
calculate specific activity (µmol min-1 mg-1) for isocitrate lyase (Table 3.7) and
glyoxylate dehydrogenase (Table 3.8). The four isolates are reported by treatment and
time point in each of the tables.
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Table 3.7

Isocitrate lyase activity (IU/mg) of copper citrate treated and untreated test
wafers exposed to L-11659-SP, FP-90848-T, TFFH 294, and L-9414-SP at
weeks 2, 4, 6, and 8. ε = 16,800 M-1cm-1. Assay volume = 0.2 mL; enzyme
volume = 0.01 mL.

Isolate

Treatment

Time
Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

6.0500
1.3667
5.6000
7.8750
4.8250
2.9333
3.5500
5.1917

0.0860
0.0917
0.0616
0.0988
0.0848
0.0976
0.0628
0.0637

Specific
Activity
(IU/mg)
0.0142
0.0671
0.0110
0.0125
0.0176
0.0333
0.0177
0.0123

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

1.2250
1.1917
5.5250
7.8889
3.2500
3.3750
4.5250
8.1778

0.1970
0.1827
0.1217
0.1360
0.1991
0.1455
0.0863
0.0664

0.1608
0.1533
0.0220
0.0172
0.0613
0.0431
0.0191
0.0081

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

1.2833
2.9250
8.9833
11.1583
1.0542
5.7889
10.3750
10.5500

0.2568
0.1574
0.1506
0.1557
0.1929
0.1455
0.1268
0.1045

0.2001
0.0538
0.0168
0.0139
0.1829
0.0251
0.0122
0.0099

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.1000
1.9889
3.0667
5.2417
0.1750
2.0833
4.6833
5.9833
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0.0851
0.1956
0.1405
0.1185
0.1970
0.1438
0.1568
0.1595

0.8512
0.0984
0.0458
0.0226
1.1259
0.0690
0.0335
0.0267

Total Protein
(mg)

Total
Units (IU)

For L-11659-SP, the highest ICL activity (0.0671 IU/mg) occurred when exposed
to the CC treatment at week 4. There are minimal differences in ICL activity between
CC and UN treatments. The CC treatment produced higher ICL activity levels than the
UN controls at weeks 4 and 8 when exposed to this isolate. FP-90848-T produced
highest ICL activity (0.1608 IU/mg) when exposed to CC at week 2. Both weeks 2 and 4
stimulated much higher ICL activity than the later weeks. The CC treatment generated
higher ICL activity levels than the UN controls for all time points when exposed to this
isolate. TFFH 294 stimulated highest ICL activity (0.2001 IU/mg) when exposed to CC
at week 2. Again, the CC treatment produced higher ICL activity than the UN controls
for all time points when exposed to this isolate. L-9414-SP exposed to UN at week 2
produced the highest ICL activity (1.1259 IU/mg) of all the isolates. Weeks 4, 8, and 8
stimulated higher ICL activity when exposed to the CC treatment for this isolate.
L-11659-SP stimulated lowest ICL activity values when compared to the other
three isolates. Highest ICL activity for each of the isolates was seen at week 2; week 4
also produced much higher activity values than the later weeks. When comparing all four
isolates, the CC treatment only stimulated higher ICL activity at weeks 4 and 6.
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Table 3.8

Glyoxylate dehydrogenase activity (IU/mg) of copper citrate treated and
untreated test wafers exposed to L-11659-SP, FP-90848-T, TFFH 294, and
L-9414-SP at weeks 2, 4, 6, and 8. ε = 19,600 M-1cm-1. Assay volume =
0.2 mL; enzyme volume = 0.01 mL.

Isolate

Treatment

Time
Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

Total
Protein
(mg)
2.4167
4.5000
6.1500
6.4445
4.2583
3.4222
3.5250
2.1722

0.0133
0.0272
0.0283
0.0224
0.0156
0.0259
0.0247
0.0133

Specific
Activity
(IU/mg)
0.0055
0.0060
0.0046
0.0035
0.0037
0.0076
0.0070
0.0061

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

3.1667
2.9167
11.0000
3.6222
1.5375
5.0333
6.2833
5.8222

0.0304
0.0311
0.0622
0.0510
0.0263
0.0224
0.0416
0.0490

0.0096
0.0107
0.0057
0.0141
0.0171
0.0045
0.0066
0.0084

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.9500
3.9250
6.1444
6.9583
0.2583
4.6167
7.6333
7.9083

0.0115
0.0349
0.0747
0.0357
0.0140
0.0385
0.0321
0.0508

0.0121
0.0089
0.0122
0.0051
0.0543
0.0083
0.0042
0.0064

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.1000
4.0556
6.9833
11.0083
0.1375
0.3189
5.8667
5.4222

0.0151
0.0395
0.0556
0.0622
0.0232
0.0259
0.0492
0.0135

0.1510
0.0097
0.0080
0.0057
0.1688
0.0811
0.0084
0.0025
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Total
Units (IU)

L-11659-SP produced highest GLOXDH activity (0.0076 IU/mg) when exposed
to UN at week 4. Like the ICL activity, there are minimal differences in GLOXDH
activity between CC and UN treatments. The UN controls produced higher ICL activity
levels than the CC treatment at weeks 4, 6, and 8 when exposed to this isolate. FP90848-T produced highest GLOXDH activity (0.0171 IU/mg) when exposed to UN at
week 2. The CC treatment generated higher GLOXDH activity levels than the UN
controls at weeks 4 and 8 when exposed to this isolate. TFFH 294 stimulated highest
GLOXDH activity (0.0543 IU/mg) when exposed to UN at week 2. The CC treatment
produced higher GLOXDH activity than the UN controls at weeks 4 and 6 when exposed
to this isolate. L-9414-SP exposed to UN at week 2 produced the highest GLOXDH
activity (0.1688 IU/mg). Only week 8 stimulated higher GLOXDH activity when
exposed to the CC treatment for this isolate. Like ICL activity, L-11659-SP stimulated
lowest GLOXDH activity values when compared to the other three isolates. Highest
GLOXDH activity for each of the isolates was seen at week 2 and continued to decrease
with respect to time.
ANOVA analysis (P = 0.05) indicated a significant difference between the two
enzymes with respect to specific activity. ICL produced much higher activity than
GLOXDH for each of the isolates exposed to both CC and UN treatments. Table 3.9
details the variation between enzymes.
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Table 3.9

Statistical (ANOVA) analysis of significant variation in specific activity
with respect to enzyme. A difference of 0.0564 between mean values
indicates the minimum significant difference.
Tukey’s
Grouping
A
B

Enzyme

Mean

ICL
GLOXDH

0.15862
0.02659

ANOVA analysis (P = 0.05) indicated a significant difference between week 2
and the other three time points with respect to specific activity. Week 2 produced much
higher activity levels for both ICL and GLOXDH. Table 3.10 details the variation
between time.
Table 3.10

Statistical (ANOVA) analysis of significant variation in specific activity
with respect to time. A difference of 0.1049 between mean values indicates
the minimum significant difference.
Tukey’s
Grouping
A
B
B
B

Time

Mean

2 Weeks
4 Weeks
6 Weeks
8 Weeks

0.24205
0.06571
0.04862
0.01187

ANOVA analysis (P = 0.05) indicated a significant difference between L-9414-SP
and the other three isolates with respect to specific activity. Both ICL and GLOXDH
total activity levels were highest in L-9414-SP. Table 3.11 details the variation between
isolate.
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Table 3.11

Statistical (ANOVA) analysis of significant variation in specific activity
with respect to isolate. A difference of 0.1048 between mean values
indicates the minimum significant difference.
Tukey’s
Grouping
A
B
B
B

Isolate

Mean

L-9414-SP
FP-90848-T
TFFH 294
L-11659-SP

0.25306
0.05347
0.05178
0.01587

ANOVA analysis (P = 0.05) indicated no significant difference between the two
treatments with respect to specific activity. Table 3.12 details the variation between
treatments.
Table 3.12

Statistical (ANOVA) analysis of significant variation in specific activity
with respect to treatment. A difference of 0.057 between mean values
indicates the minimum significant difference.
Tukey’s
Grouping
A
A

Treatment

Mean

Untreated
Copper Citrate

0.09705
0.08866

There was no detectable enzymatic activity for fumarase, malate synthase, and
oxaloacetase for all isolates exposed to both treatments. However, all samples tested for
fumarase, malate synthase, and oxaloacetase activity increased in protein concentration
over the 8 week period. Measurable protein could be an indication of the production of
proteins unrelated to these three enzymes.
Specific activity details the proclivity of an enzyme. The activity of an enzyme is
dependent on the amount of total protein in the sample and indicates how efficiently it
can convert substrate to product under the given conditions. For this study, the specific
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activity of ICL and GLOXDH was determined using the change in absorbance per minute
(ΔA/min) and the protein concentration of the crude-homogenate in each of the test
samples. Because the crude-homogenate was used to measure protein concentration, the
specific enzyme was not the only measurable protein in the crude-homogenate mixture.
It is highly likely that the protein assay measured a variety of proteins and metabolites
present in the crude-homogenate sample. This could explain the low specific activity
values for both ICL and GLOXDH. It could also explain why FUM, MS, and OAA had
undetectable activity (ΔA/min). If other metabolites and proteins were present in the
crude-homogenate, it is possible that they could have interfered with FUM, MS, and
OAA detection. Theoretically, all five enzymes should have been detected because they
are important components in the TCA and GLOX cycles (Figure 1.1). However, because
only ICL and GLOXDH showed activity (ΔA/min), it is probable that FUM, MS, and
OAA were undetectable because they existed in low quantities.
ICL is a central enzyme in the production of oxalate (Munir et al. 2001). In this
study, ICL production was significantly higher than GLOXDH production for the four
isolates (Table 3.9). In theory, ICL production should be higher because it feeds into
both the TCA and GLOX cycles (Figure 1.1). In the TCA cycle, ICL converts isocitrate
to glyoxylate. ICL is also found in the GLOX cycle and again converts isocitrate to
glyoxylate. For all four isolates, ICL activity was highest at week 2 for both CC and UN
treated wood. Because ICL generates glyoxylate, it would make sense for it to be highly
produced at the earlier time points. In all four isolates, oxalate production was
significantly lower at week 2 (Table 3.1). If ICL is a central enzyme in oxalate
production, it would need time to convert enough glyoxylate before oxalate levels start
increasing. At week 4, the CC treatment generated higher ICL activity than the UN
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controls. The CC treatment started generating higher oxalate production when compared
to the UN controls at week 8 (Figure 3.5). This could also be a reflection of the amount
of time needed by the fungus to overcome initial exposure to copper and start efficiently
generating oxalate in higher quantities.
GLOXDH has been linked to the direct production of oxalate (Munir et al. 2001;
Yoon et al. 2002). The GLOX cycle produces glyoxylate which leaves the cycle to be
acted on by GLOXDH to produce oxalate (Figure 1.1). GLOXDH is expressed
significantly lower than ICL (Table 3.9), which makes sense because GLOXDH is only
found in the GLOX cycle. Theoretically, if GLOXDH is a key factor in the biosynthesis
of oxalate it should reflect the same patterns in both oxalate production and enzyme
activity for the four isolates. It is important to note that the differences between the CC
and UN treatments in oxalate production (Figure 3.6) correlate to the differences between
the CC and UN treatments in GLOXDH activity (Table 3.8) for FP-90848-T, TFFH 294,
and L-9414-SP.
Evaluating the Role of Oxalate: Gene Expression Analysis Results
The purpose of this study was to determine expression levels of specific genes
within L-11659-SP, FP-98048-T, TFFH 294, and L-9414-SP undergoing decay of 1.2%
copper citrate (CC) treated and untreated (UN) SYP wafers. Extracted RNA from each
test sample was converted to cDNA, which was used to evaluate expression levels of five
genes thought to be involved in oxalate production. Fold change was determined for all
samples using TFFH 294 exposed to untreated controls at week 4 as the endogenous
control.
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RNA Quantification
After the samples were successfully extracted for RNA, the quantity and quality
was evaluated by Experion chip electrophoresis. Figure 3.11 shows the integrity of
RNA for the 32 samples used for gene expression. Because of poor quality and RNA
degradation, several samples had to be re-extracted and can be seen in Figure 3.11D.
After re-extraction, samples did not demonstrate RNA degradation.
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Figure 3.11

Gel image of extracted RNA for gene expression analysis: Ladders are
designated L; (A) wells are 1, rat brain RNA; 2 – 9, L-11659-SP w2-8; 10 –
12, FP-90848-T w2-4; CC treatment even wells; UN treatment odd wells;
(B) wells are 1, rat brain RNA; 2 – 6, FP-90848-T w4-8; 7 – 12, L-9414-SP
w2-6; UN treatment even wells, CC treatment odd wells; (C) wells are 1,
rat brain RNA; 2 – 3, L-9414-SP w8; 4 – 11, TFFH 294 w2-8; CC
treatment even wells; UN treatment odd wells; (D) wells are 1, L-11659-SP
CC w2; 2 – 8, L-9414-SP w4-8 UN even wells, CC odd wells; 9 – 12,
TFFH 294 UN wk2-8.
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cDNA Synthesis and Primer Design
Two cDNA synthesis protocols (iScript cDNA Synthesis and Invitrogen
SuperScript II Reverse Transcriptase) were performed on the 32 samples used for gene
expression. To determine the more efficient protocol, a conventional PCR amplification
of cDNA from a small sample set (L-11659-SP, FP-90848-T, TFFH 294, and L-9414-SP;
CC week 2) was carried out to verify if the target regions were being actively produced
by all four isolates. Target regions in question were isocitrate lyase (ICL), glyoxylate
dehydrogenase (GLOXDH), citrate synthase (CS), succinate/fumarate antiporter (ANTI),
and the copper resistance-associated ATPase pump (ATPase). Gel electrophoresis of the
amplified PCR products demonstrated that the four samples generated appropriate basepair length bands for each of the target regions in question.
Bio-Rad iQ iScript
RNA was synthesized to first strand cDNA by the Bio-Rad iScript cDNA
Synthesis protocol for the four samples. Amplified PCR products for ICL, GLOXDH,
CS, ANTI, and ATPase target regions can be seen in Figure 3.12. Multiple bands are
seen for all five target regions. Based on the size of the band, the second band is the
result of DNA contamination of an intron due to inefficient priming.
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Figure 3.12

Gel image of the Bio-Rad iScript cDNA Synthesis protocol. Ladders are
on the outer lanes. The four samples were amplified for all target regions;
L-11659-SP, FP-90848-T, TFFH 294, and L-9414-SP. Bottom row lanes: 1
– 4, 18S; 5 – 8, ICL; 9 – 12, GLOXDH. Top row lanes: 1 – 4, CS; 5 – 8,
ANTI; 9-12, ATPase.
Invitrogen SuperScript II Reverse Transcriptase

RNA was synthesized to first strand cDNA by the Invitrogen SuperScript II
Reverse Transcriptase protocol for the four samples. Amplified PCR products for ICL,
GLOXDH, CS, ANTI, and ATPase target regions can be seen in Figure 3.13. Multiple
bands were not seen for the majority of the target regions (exception L-9414-SP CS) with
this cDNA synthesis protocol. The ICL region was not pictured in this gel; however, it
showed no double band for the four samples.
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Figure 3.13

Gel image of the Invitrogen SuperScript II Reverse Transcriptase
protocol. Ladders are on the outer lanes. The four samples were amplified
for all target regions; L-11659-SP, FP-90848-T, TFFH 294, and L-9419SP. From left to right lanes: 1 – 4, 18S; 5 – 8, GLOXDH; 9 – 12, CS; 13 –
16, ANTI; 17 – 20, ATPase. Lane 21 is the non-template control (no band).

The Bio-Rad iScript cDNA Synthesis protocol uses both random hexamers and
oligo dT primers to generate cDNA synthesis. Random hexamers target random points in
the sequence to initiate cDNA synthesis, while oligo dT primers target the 3’ poly A
sequence to begin cDNA synthesis. The Invitrogen SuperScript II Reverse
Transcriptase protocol only uses oligo dT primers to generate cDNA synthesis.
Inefficiency of the Bio-Rad protocol could be a result of the use of random hexamers,
which could have a higher probability of amplifying DNA contaminates when used in
combination with the five target primers designed for this study. It is evident that the
Invitrogen protocol produced target regions that were not contaminated by DNA
(Figure 3.13). For these reasons, cDNA synthesized by the Invitrogen SuperScript II
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Reverse Transcriptase protocol was used to measure expression levels of ICL, GLOXDH,
CS, ANTI, and ATPase.
Expression Levels
Real-time qPCR was used to analyze CT values of the test samples for ICL,
GLOXDH, CS, ANTI, and ATPase genes. Using the actin (HK) mean CT, average
replicate CT values were normalized for all plates. Normalized CT values were used to
calculate the mean fold change (2-∆∆CT) in expression of the five genes using the
comparative CT method (Livak and Schmittgen 2001). TFFH 294 exposed to UN
controls at week 4 was used as the endogenous control for all calculations. In the
subsequent graphs, the expression level for the endogenous control is set at 1. If the other
isolates/time points expression levels are above 1, expression is increased by a certain
factor, which results in a higher gene production for the respective sample. If expression
levels are below 1, expression is decreased, which results in a lower gene production for
the respective sample.
Relative changes in ICL expression for each isolate with respect to time can be
seen in Figure 3.14 and 3.15. Dark colors (green, blue, red, and purple) represent CC
treatment and light colors represent UN treatment (Figure 3.14). In general, there was
not a large variation in fold change values between treatment, isolate, and time for ICL
with respect to the endogenous control. L-9414-SP exposed to CC at week 2 had the
highest fold change difference (5.352) when compared to the other three isolates. The
CC treatment generated higher fold change differences when compared to the UN
controls for TFFH 294 and L-9414-SP at week 2 and L-11659-SP at week 6.
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Figure 3.14

Isocitrate lyase expression levels of L-11659-SP (green), FP-90848-T
(blue), TFFH 294 (red), and L-9414-SP (purple) exposed to copper citrate
(CC) and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

Dark colors (green, blue, red, and purple) represent CC treatment and light colors
represent UN treatment (Figure 3.15). L-11659-SP and TFFH 294 had the largest fold
change difference in comparison to the other three isolates. Interestingly, FP-90848-T
showed low expression levels at all time points when compared to the endogenous
control. With the exception of the CC treatment at week 2, L-9414-SP also had lower
expression levels when compared to the endogenous control. Nearly all of the isolates at
the four time points showed higher expression levels in the UN controls when compared
to the CC treatment.
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Figure 3.15

Isocitrate lyase expression levels for 2 weeks (green), 4 weeks (blue), 6
weeks (red) and 8 weeks (purple) for isolates L-11659-SP, FP-90848-T,
TFFH 294, and L-9414-SP exposed to copper citrate (CC) and untreated
(UN) test wafers.

Relative changes in GLOXDH expression for each isolate with respect to time can
be seen in Figures 3.16 and 3.17. Dark colors (green, blue, red, and purple) represent CC
treatment and light colors represent UN treatment (Figure 3.16). Like ICL expression
levels, there was not a large variation in fold change values between treatment, isolate,
and time for GLOXDH with respect to the endogenous control (TFFH 294 UN w4) with
a few exceptions. L-9414-SP exposed to CC at week 2 had the highest fold change
difference (5.657) when compared to the other three isolates. The CC treatment
generated higher expression of GLOXDH for L-11659-SP, TFFH 294, and L-9414-SP
when compared to the UN controls at week 2 but not at the other time points. L-11659SP exposed to CC at week 6 also showed higher expression levels than UN controls.
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Figure 3.16

Glyoxylate dehydrogenase expression levels of L-11659-SP (green), FP90848-T (blue), TFFH 294 (red), and L-9414-SP (purple) exposed to
copper citrate (CC) and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

Dark colors (green, blue, red, and purple) represent CC treatment and light colors
represent UN treatment (Figure 3.17). Overall, L-11659-SP had the largest fold change
difference in comparison to the endogenous control and the other three isolates for the
four time points. FP-90848-T had the lowest GLOXDH expression when compared to
the other isolates. The CC treatment did not stimulate higher GLOXDH expression
levels than the UN controls for FP-90848-T. The UN controls showed lower expression
levels than the CC treatment for L-9414-SP at weeks 2, 6, and 8. TFFH 294 showed
higher expression on CC treated wood at week 2 only, while L-11659-SP showed higher
expression on CC treated wood at weeks 2 and 6.
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Figure 3.17

Glyoxylate dehydrogenase expression levels for 2 weeks (green), 4 weeks
(blue), 6 weeks (red) and 8 weeks (purple) for isolates L-11659-SP, FP90848-T, TFFH 294, and L-9414-SP exposed to copper citrate (CC) and
untreated (UN) test wafers.

Relative changes in CS expression for each isolate with respect to time can be
seen in Figures 3.18 and 3.19. Dark colors (green, blue, red, and purple) represent CC
treatment and light colors represent UN treatment (Figure 3.18). Like ICL and
GLOXDH expression levels, CS fold change differences do not largely vary between
isolate, treatment, and time with respect to the endogenous control (TFFH 294 UN w4).
Like GLOXDH, week 2 shows higher fold change differences for L-11659-SP, TFFH
294, and L-9414-SP for the CC treatment in comparison to the UN controls. L-9414-SP
exposed to CC at week 2 had the highest fold change difference (4.724) when compared
to the other three isolates. Week 6 for both CC and UN treatments showed lower fold
change differences in comparison to all other time points.
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Figure 3.18

Citrate synthase expression levels of L-11659-SP (green), FP-90848-T
(blue), TFFH 294 (red), and L-9414-SP (purple) exposed to copper citrate
(CC) and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

Dark colors (green, blue, red, and purple) represent CC treatment and light colors
represent UN treatment (Figure 3.19). Overall, L-11659-SP had the largest CS
expression in comparison to the other isolates. Both FP-90848-T and L-9414-SP had the
smallest overall CS expression levels. There was no variation in fold change differences
between weeks and treatment when exposed to TFFH 294 until week 8. The CC
treatment did not stimulate higher CS expression levels than the UN controls for FP90848-T except for week 8 where the CC treatment was slightly higher than the UN
controls. The UN controls showed lower expression levels than the CC treatment for L11659-SP at weeks 2, 6, and 8. TFFH 294 showed higher expression on CC treated wood
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at week 2 only. L-9414-SP showed a much higher expression on CC treated wood at
weeks 2 than the UN controls.

Figure 3.19

Citrate synthase expression levels for 2 weeks (green), 4 weeks (blue), 6
weeks (red) and 8 weeks (purple) for isolates L-11659-SP, FP-90848-T,
TFFH 294, and L-9414-SP exposed to copper citrate (CC) and untreated
(UN) test wafers.

Relative changes in ANTI expression for each isolate with respect to time can be
seen in Figures 3.20 and 3.21. Dark colors (green, blue, red, and purple) represent CC
treatment and light colors represent UN treatment (Figure 3.20). Again, there is an
overall lower variability in ANTI expression with respect to the endogenous control
(TFFH 294 UN w4). L-9414-SP exposed to CC at week 2 had the highest fold change
difference (6.964) when compared to the other three isolates. UN controls had higher
ANTI expression than the CC treatment at week 4 for all isolates.
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Figure 3.20

Antiporter expression levels of L-11659-SP (green), FP-90848-T (blue),
TFFH 294 (red), and L-9414-SP (purple) exposed to copper citrate (CC)
and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

Dark colors (green, blue, red, and purple) represent CC treatment and light colors
represent UN treatment (Figure 3.21). L-11659-SP had the highest overall ANTI
expression in comparison to the other isolates. Both FP-90848-T and L-9414-SP had
lower ANTI expression than L-11659-SP and TFFH 294. Like CS, the CC treatment did
not stimulate higher ANTI expression levels than the UN controls for FP-90848-T except
for week 8 where the CC treatment was slightly higher than the UN controls. The UN
controls showed lower expression levels than the CC treatment for L-9414-SP at weeks 2,
6, and 8. TFFH 294 only showed slightly higher expression on CC treated wood at week
2 and 4. L-11659-SP showed higher expression on CC treated wood at weeks 2 and 6.
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Figure 3.21

Antiporter expression levels for 2 weeks (green), 4 weeks (blue), 6 weeks
(red) and 8 weeks (purple) for isolates L-11659-SP, FP-90848-T, TFFH
294, and L-9414-SP exposed to copper citrate (CC) and untreated (UN) test
wafers.

Relative changes in ATPase expression for each isolate with respect to time can
be seen in Figures 3.22 and 3.23. Dark colors (green, blue, red, and purple) represent CC
treatment and light colors represent UN treatment (Figure 3.22). There were large
fluctuations in ATPase expression levels between treatment, isolate, and time for ATPase
with respect to the endogenous control (TFFH 294 UN w4). Nearly all of the samples
had much higher expression levels when compared to the endogenous control. The
largest fold change difference (15.455) was seen in L-11659-SP exposed to CC at week
4. Week 8 had much lower expression of ATPase with respect to the other three time
points.
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Figure 3.22

ATPase pump expression levels of L-11659-SP (green), FP-90848-T
(blue), TFFH 294 (red), and L-9414-SP (purple) exposed to copper citrate
(CC) and untreated (UN) test wafers for 2, 4, 6, and 8 weeks.

Dark colors (green, blue, red, and purple) represent CC treatment and light colors
represent UN treatment (Figure 3.23). L-9414-SP had the largest fold change difference
in comparison to the other three isolates. The CC treatment generated much higher
expression levels than the UN controls for all isolates at weeks 2 and 4. FP-90848-T and
L-9414-SP also show much higher expression levels for the CC treatment than the UN
controls at week 6. Again, L-9414-SP showed a considerably higher ATPase expression
in the CC treatment than the UN control at week 8.
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Figure 3.23

ATPase pump expression levels for 2 weeks (green), 4 weeks (blue), 6
weeks (red) and 8 weeks (purple) for isolates L-11659-SP, FP-90848-T,
TFFH 294, and L-9414-SP exposed to copper citrate (CC) and untreated
(UN) test wafers.

Evaluating gene expression is a more sensitive approach in determining the active
participants in the biosynthesis of oxalate. Both ICL and GLOXDH were analyzed for
expression because the crude-homogenate mixtures demonstrated quantifiable enzyme
activity in the four isolates over the course of the study. FUM, MS, and OAA were not
evaluated for expression because the crude-homogenate failed to demonstrate measurable
enzyme activity in the same test samples. Based on the genome analysis of TFFH 294 by
Tang (2011), three other genes were included and measured for expression levels. Tang
(2011) found that citrate synthase (CS), a succinate-fumarate antiporter (ANTI), and a
copper resistance ATPase pump (ATPase) were up-regulated in the early stages of decay.
It is important to note, that ICL and GLOXDH were also up-regulated in the early stages
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of decay (Tang 2011). Citrate synthase is found in the mitochondria as part of the TCA
cycle and converts oxaloacetate to citrate (Figure 3.24). The succinate/fumarate
antiporter, found in the cytoplasm, functions as the shunt from isocitrate in the TCA cycle
to isocitrate in the GLOX cycle which is located in the glyoxysome (Figure 3.24). The
ATPase pump is not associated with either the TCA or GLOX cycles; instead, it is found
in the cytoplasm and functions to pump copper ions (Cu2+) out of the cell (Figure 3.24).
Because these five genes are up-regulated at the earlier stages of decay, it would be
expected that expression levels should be observed in the samples used for this study.

Figure 3.24

Genes up-regulated in early decay; genes are in red. (A) TCA cycle; (B)
GLOX cycle. Green box indicates TCA cycle in the mitochondria; orange
box indicates GLOX cycle in the glyoxysome (Tang 2011).

Expression levels of the five genes were seen in all isolates through the 8 week
period; however, the expression patterns did not directly correlate to the patterns seen in
oxalate production (Figure 3.6). For ICL, GLOXDH, CS, and ANTI, expression levels
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were highest in L-9414-SP exposed to CC at week 2 when compared to the other isolates.
Highest oxalate production for L-9414-SP was not seen until week 6 (Figure 3.6). It is
possible that the genes are being expressed much sooner than the appearance of end
product. For example, elevated ICL expression could occur after a few days, which may
not be reflected in oxalate production until week 4 or 6. The same could hold true for
GLOXDH expression. It would be expected that elevated ICL expression would occur
before elevated GLOXDH expression since glyoxylate needs to be produced before
oxalate can be produced (Figure 3.24). However, both of these enzymes could have been
expressed much higher prior to the first time point evaluated in this study. Also, it would
be expected that CS, ANTI, ICL, and GLOXDH expression levels would be connected
based on their location in the TCA cycle (Figure 3.24).
If copper functions to initiate a response in elevated oxalate production, it should
be reflected in the expression levels of all five genes. It is possible for levels of
expression to fluctuate based on isolate and time, which could be dependent on the
metabolism of the particular isolate. ATPase expression levels are higher for all isolates
exposed to CC treatment when compared to the UN controls over the course of the study
(Figure 3.22). It is probable that the presence of copper in the CC treatment causes the
increase in expression of ATPase through week 8 for all isolates. Since the ATPase
pumps copper out of the cell, it would be expected that in a copper-rich environment
expression would be higher. The organism would need to efficiently pump the copper
ions out to keep the copper from building to a toxic level in the cell. It can also be
deduced that the organism would need to pump out the copper ions at the earliest stage
possible, which would show much higher ATPase expression in copper-rich
environments when compared to untreated environments. The biggest difference
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between the CC and UN treatments were seen at week 2 in TFFH 294, week 4 in L11659-SP, and week 6 in FP-90848-T and L-9414-SP (Figure 3.23). The elevated
ATPase expression could reflect differences between the two treatments seen in oxalate
production of these four isolates (Figure 3.6).
Evaluating the Role of Oxalate: The Effects of Copper Availability
The purpose of this study was to determine if alternating applications of copper
citrate led to differences in the response of the isolates over time. Four variations of
1.2% ammoniacal copper citrate treatments as well as an untreated control were analyzed
for oxalate concentration and % weight loss. SYP blocks tested for oxalate production
were untreated blocks (UN), 1.2% ammoniacal copper citrate blocks (CC), untreated
blocks stacked underneath 1.2% ammoniacal copper citrate blocks (ST), and 100µl of
1.2% ammoniacal copper citrate added to untreated blocks (LIQ); blocks from each test
configuration were analyzed every two weeks over an eight week period. Oxalate
production of untreated blocks replaced with 1.2% ammoniacal copper citrate blocks
(RP) every two weeks was only analyzed every two weeks for a six week period.
Concentration values shown in the figures are the average of six biological replicates.
Oxalate Assay
Differences in L-11659-SP oxalate concentration (mg/mL) between the five
treatments with respect to time can be seen in Figure 3.25. Treatments are distinguished
based on color: UN (green), CC (blue), ST (red), LIQ (purple), and RP (orange). L11659-SP exposed to the ST treatment stimulated highest oxalate production (0.481
mg/mL) at week 8. Lowest production of oxalate was at week 2 with ST, LIQ, and RP,
week 4 with UN, and week 6 with CC treatments. Highest oxalate concentrations were at
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week 4 with CC, week 6 with RP, and week 8 with UN, ST, and LIQ. Minimal changes
in oxalate concentration were observed when exposed to UN over the eight week period.
Concentration values continually increased over time when exposed to ST. No change in
oxalate concentration was seen from week 4 through week 8 when exposed to LIQ. With
the exception of ST and LIQ treatments at week 2, oxalate concentrations are higher for
all copper variations with respect to time when compared to untreated controls.

Figure 3.25

Oxalate concentration values (mg/mL) of L-11659-SP exposed to UN
(green), CC (blue), ST (red), LIQ (purple), and RP (orange) SYP blocks
with respect to time.

Variations in oxalate concentration (mg/mL) for FP-90848-T between the five
treatments with respect to time can been seen in Figure 3.26. Again, treatments are
distinguished based on color: UN (green), CC (blue), ST (red), LIQ (purple), and RP
93

(orange). In FP-90848-T, the ST and LIQ treatments stimulated highest oxalate
production (1.396 mg/mL and 1.424 mg/mL, respectively) at week 6. Overall, week 2
had the lowest oxalate production for all five treatments when exposed to this isolate.
Highest oxalate concentrations were seen at week 6 for all five treatments. Increasing
oxalate concentration was observed from week 2 through week 6 and then decreased
from week 6 to week 8 for most of the treatments (no change observed in CC from week
6 to week 8). Unlike L-11659-SP, oxalate concentration was not higher for all copper
variations when compared to untreated controls.

Figure 3.26

Oxalate concentration values (mg/mL) of FP-90848-T exposed to UN
(green), CC (blue), ST (red), LIQ (purple), and RP (orange) SYP blocks
with respect to time.
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For TFFH 294, variations in oxalate concentration (mg/mL) between the five
treatments with respect to time can been seen in Figure 3.27. Following the same pattern
above, treatments are distinguished based on color: UN (green), CC (blue), ST (red), LIQ
(purple), and RP (orange). Overall, TFFH 294 did not grow well and oxalate values
fluctuated over the course of the study with respect to both time and treatment. None of
the treatments were able to produce oxalate values higher than 0.150 mg/mL over the
eight week period. TFFH 294 produced highest oxalate values when exposed to LIQ and
RP treatments. Because of the high variability of the data, it is hard to differentiate the
time point that stimulated the highest and lowest production of oxalate with respect to
treatment.

Figure 3.27

Oxalate concentration values (mg/mL) of TFFH 294 exposed to UN
(green), CC (blue), ST (red), LIQ (purple), and RP (orange) SYP blocks
with respect to time.
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Differences in oxalate concentration (mg/mL) for L-9414-SP between the five
treatments with respect to time can been seen in Figure 3.28. Again, all treatments are
distinguished based on color: UN (green), CC (blue), ST (red), LIQ (purple), and RP
(orange). L-9414-SP exposed to the ST treatment stimulated the highest oxalate
production (0.509 mg/mL) at week 6. The lowest oxalate production for the five
treatments exposed to this isolate was at week 2. Highest oxalate concentrations were
observed at week 6 for all treatments. Like FP-90848-T, increasing oxalate concentration
was observed from week 2 through week 6 and then decreased from week 6 to week 8 for
most of the treatments (no change observed in CC from week 6 to week 8). The copper
treatments did not stimulate higher oxalate values when compared to untreated controls
until weeks 6 and 8.
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Figure 3.28

Oxalate concentration values (mg/mL) of L-9414-SP exposed to UN
(green), CC (blue), ST (red), LIQ (purple), and RP (orange) SYP blocks
with respect to time.

ANOVA analysis (P = 0.05) indicated that oxalate production in the ST treatment
was significantly greater than the other four treatments. The UN, CC, LIQ, and RP
treatments were not significantly different from each other. Table 3.13 details the
variation between treatments; a difference of 0.0602 between mean values signifies the
minimum significant difference.

97

Table 3.13

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to treatment. A is significantly different than B.
Tukey’s
Grouping
A
B
B
B
B

Treatment

Mean

ST
CC
LIQ
UN
RP

0.31047
0.23262
0.22297
0.18252
0.17844

Statistical analysis also showed both isolates and time were significantly different
from each other with respect to oxalate production. Table 3.14 and 3.15 detail variations
between isolates and time, respectively.
Table 3.14

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to isolate. A difference of 0.0488 between mean values
indicates the minimum significant difference.
Tukey’s
Grouping
A
B
C
D

Table 3.15

Isolate

Mean

FP-90848-T
L-9414-SP
L-11659-SP
TFFH 294

0.31047
0.23262
0.22297
0.18252

Statistical (ANOVA) analysis of significant variation in oxalate production
with respect to time. A difference of 0.0489 between mean values indicates
the minimum significant difference.
Tukey’s
Grouping
A
B
C
D

Time

Mean

6 weeks
8 weeks
4 weeks
2 weeks

0.31047
0.23262
0.22297
0.18252
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With the exception of RP, the copper treatments produced higher amounts of
oxalate than the untreated controls (Table 3.13). However, based on the statistical
analysis, only the ST treatment showed a significant difference in oxalate concentration.
FP-90848-T generated the highest amount of oxalate with respect to treatment and time
(Table 3.14). According to the statistical data, week 6 gave highest oxalate
concentrations, while week 2 gave the lowest (Table 3.15).
Oxalate plays an important role in the ability of F. radiculosa to tolerate copper.
This study was designed to evaluate changes in the response of the four isolates to
different applications of copper citrate. Because TFFH 294 had difficulty growing, its
validity in this study is in question. Any comparisons made between TFFH 294 and the
other three isolates are likely not biologically relevant. Statistical analysis indicated the
ST treatment produced significantly higher oxalate amounts than the other treatments
(Table 3.13). It is possible the increased oxalate production seen in the ST treatment
could be a result of greater surface contact between the UN test block and the CC test
block stacked above. Theoretically, the UN test block could be stimulated by contact
with copper ions in the CC test block. In any case, it is evident that stacking the CC test
block above the UN test block stimulated a higher production of oxalate for L-11659-SP,
FP-90848-T, and L-9414-SP over the eight week time period.
In the RP treatment, UN test blocks were also in direct contact with CC test
blocks; however, there was no significant difference in oxalate production when
compared to the other treatments (Table 3.13). In fact, the RP treatment produced the
lowest oxalate amounts in comparison to the other treatments. One difference between
the RP and ST treatments was the orientation of the UN and CC test blocks. In the RP
treatment, the CC test block was in direct contact with one side of the UN test block;
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because it was not stacked above the UN test block, the cross section face of neither
block was in direct contact. The low oxalate production indicates that this type of contact
did not facilitate the production of more oxalate in these isolates. The isolates were not
able to obtain the copper ions as readily unless the cross section face of the treated block
was in direct contact with the untreated block as was the case in the ST variation. Based
on oxalate production in the ST and RP treatments, it is possible that the placement of the
CC test blocks in relation to the UN test blocks has an effect on the organisms’
accessibility in obtaining the copper ions from the CC test blocks.
There are similarities in oxalate production between this study and the previous
study (Evaluating the Role of Oxalate: Enzyme Analysis Results). The amount of oxalate
produced by the isolates throughout the course of this study (Table 3.14) mirrors the
amount of oxalate produced in the previous study (Table 3.2). However, for this study
oxalate production is significantly different between each isolate (Table 3.14). Oxalate
production based on weeks in this study (Table 3.15) also reflects the oxalate production
seen in the previous study (Table 3.1). Based on the repeatable data in these two studies,
it can be inferred that the oxalate production seen is a true representation for these
particular isolates exposed to CC and UN wood.
Weight Loss
Decay capacity was determined by recording the weight of the test blocks preexposure and post-exposure for each sampling time point. The weights of the blocks
were used to calculate % weight loss over time. Values seen in the graphs below are the
average of six biological replicates. Differences in the % weight loss of L-11659-SP
between the five treatments with respect to time can be seen in Figure 3.29. Treatments
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are distinguished based on color: UN (green), CC (blue), ST (red), LIQ (purple), and RP
(orange). When exposed to the ST treatment, L-11659-SP had the highest % weight loss
at week 8 (23%). The CC treatment at week 6 had the lowest % weight loss when
exposed to this organism. Smallest % weight loss was seen at week 2 for most of the
treatments (CC week 6 was the only exception). Overall, the last sampling time point
generated the largest % weight loss for all treatments. With the exception of the CC
treatment, the UN controls had lower % weight loss when compared to the various
copper treatments throughout the eight week period.

Figure 3.29

Weight loss percentages of L-11659-SP exposed to UN (green), CC (blue),
ST (red), LIQ (purple), and RP (orange) SYP blocks with respect to time

Differences in the % weight loss of FP-90848-T between the five treatments with
respect to time can be seen in Figure 3.30. Again, treatments are distinguished based on
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color: UN (green), CC (blue), ST (red), LIQ (purple), and RP (orange). FP-90848-T had
the highest % weight loss at week 6 (28%) when exposed to the RP treatment. The CC
treatment at week 2 had the lowest % weight loss when exposed to this organism.
Smallest % weight loss was seen at week 2 for all five treatments. Like L-11659-SP, the
last sampling time point generated the largest % weight loss for all treatments. When
compared to the UN controls, only the ST and RP treatments had higher % weight loss
with respect to time. In this organism, % weight loss increases over time for all
treatments.

Figure 3.30

Weight loss percentages of FP-90848-T exposed to UN (green), CC (blue),
ST (red), LIQ (purple), and RP (orange) SYP blocks with respect to time.

Differences in the % weight loss of TFFH 294 between the five treatments with
respect to time can be seen in Figure 3.31. Again, treatments are distinguished based on
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color: UN (green), CC (blue), ST (red), LIQ (purple), and RP (orange). Because TFFH
294 did not grow well during this experiment, decay capacity is hard to establish based
on the results shown in Figure 3.15. The highest % weight loss was seen at week 8
(33.5%) when exposed to the ST treatment. Smallest % weight loss was seen at week 2
for all five treatments. Again, because of the lack of data, it is hard to accurately pinpoint
the time point and treatment that stimulated the highest and lowest % weight loss.

Figure 3.31

Weight loss percentages of TFFH 294 exposed to UN (green), CC (blue),
ST (red), LIQ (purple), and RP (orange) SYP blocks with respect to time.

Differences in the % weight loss of L-9414-SP between the five treatments with
respect to time can be seen in Figure 3.32. As before, treatments are distinguished based
on color: UN (green), CC (blue), ST (red), LIQ (purple), and RP (orange). L-9414-SP
had the highest % weight loss at week 8 (38.6%) when exposed to both the ST and LIQ
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treatments. The UN and LIQ treatments at week 2 had the lowest % weight loss when
exposed to this organism. Like L-11659-SP and FP-90848-T, the smallest % weight loss
was seen at week 2 for all five treatments. Again, the last sampling time point generated
the largest % weight loss for all treatments. When compared to the UN controls, the ST,
LIQ, and RP treatments had higher % weight loss with respect to time. Like FP-90848-T,
% weight loss increased over time for all treatments.

Figure 3.32

Weight loss percentages of L-9414-SP exposed to UN (green), CC (blue),
ST (red), LIQ (purple), and RP (orange) SYP blocks with respect to time.

ANOVA analysis (P = 0.05) indicated that the ST, LIQ, and CC treatment were
significantly different with respect to % weight loss. The UN controls and RP treatment
were not significantly different from each other, but were significantly different than the
other three treatments with respect to % weight loss. Table 3.16 details the variation
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between treatments; a difference of 1.5678 between mean values signifies the minimum
significant difference.
Table 3.16

Statistical (ANOVA) analysis of significant variation between treatments
with respect to % weight loss.
Tukey’s
Grouping
A
B
C
C
D

Treatment

Mean

ST
LIQ
UN
RP
CC

16.9272
14.2775
12.3102
12.2781
6.8888

Statistical analysis also showed isolates L-9414-SP and FP-90848-T were not
significantly different from each other. Table 3.17 shows the variation between isolates
with respect to % weight loss. Each time point was significantly different from each
other with respect to % weight loss. Table 3.18 details the variations between the four
time points.
Table 3.17

Statistical (ANOVA) analysis of significant variation in % weight loss with
respect to isolate. A difference of 1.2703 between mean values indicates the
minimum significant difference.
Tukey’s
Grouping
A
A
B

Isolate

Mean

L-9414-SP
FP-90848-T
L-11659-SP

17.8288
16.7435
9.2397
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Table 3.18

Statistical (ANOVA) analysis of significant variation in % weight loss with
respect to time. A difference of 1.2731 between mean values indicates the
minimum significant difference.
Tukey’s
Grouping
A
B
C
D

Time

Mean

8 weeks
6 weeks
4 weeks
2 weeks

22.6865
15.7847
10.8201
2.4149

L-9414-SP generated the highest % weight loss with respect to treatment and
time, while TFFH 294 produced the lowest amount (Table 3.16). According to the
statistical data, week 8 gave the highest % weight loss, while week 2 gave the lowest
(Table 3.17). In comparison to the statistical data for oxalate production, it can be
inferred that oxalate alone is not the only factor contributing to the decay capacity of the
wood. This can hold true based on the fact that for oxalate production the ST treatment
was the only significantly different treatment with respect to time and isolate (Table
3.13); however, in the % weight loss analysis multiple treatments are significantly
different with respect to time and isolate (Table 3.18).
The purpose of measuring weight loss is to determine the decay capacity of the
organisms in a given environment. In this study, decay capacity can be directly related to
the isolate’s ability to degrade wood treated with different variations of copper citrate
availability. Again, comparisons are made excluding TFFH 294 because its validity in
this study remains in question. Once the organism initiates decay, it would be expected
that percent weight loss would continue to increase over time. In L-11659-SP, all
treatments, with the exception of CC at week 6, continually increased in weight loss with
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respect to time (Figure 3.29). Both FP-90848-T and L-9414-SP showed an increase in
weight loss for all five treatments with respect to time (Figure 3.30 and 3.32,
respectively). This indicates that L-11659-SP, FP-90848-T, and L-9414-SP efficiently
degraded the wood regardless of the treatment. Statistical analysis showed significantly
higher weight loss at week 8 (Table 3.18). The analysis also indicated a significant
increase in weight loss for each time point (Table 3.18). This makes sense because it
would be expected that the breakdown of wood components would continue to increase
as time progresses unless the preservative treatment is toxic to the organism.
Interestingly, the statistical analysis showed a significant difference in all
treatments except UN and RP, which were not significantly different (Table 3.16). This
suggests that the isolates function differently metabolically when breaking down the
treatments, depending on the delivery of copper to the wood. The CC treatment showed
significantly lower weight loss than the other treatments (Table 3.16). This could be
caused by the organisms’ need to detoxify the copper ions before obtaining nutrients
from the wood. It is also possible that the isolates take longer to adapt to the toxic
properties of copper when the ions have been fixed into the wood, which would be
reflected in a lower weight loss percentage. Therefore, a delay in the organism having to
come in contact with copper is helpful in establishing the growth, especially across any
copper gradient. The LIQ treatment showed the second highest weight loss indicating the
copper ions did not affect the organisms’ ability to efficiently degrade the wood (Table
3.16). This could be due to the fact that the copper ions were on the surface of the wood
in the LIQ treatment. This could be an indication that adaptation is more favorable across
a gradient from low to high copper.
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CHAPTER IV
CONCLUSIONS
•

The four isolates showed variability in oxalate production, protein production,
enzyme activity, and gene expression when compared to each other over the
course of this study. This could be credited to a number of factors: adaptability,
environment, growth, metabolism, and exposure time.

•

While the isolates were in the “adaptation” phase, protein production was
relatively low. It is possible that this may have been a reflection of the organism
acclimating to the surrounding environment. After adaptation, protein production
increases over time, which could indicate the active breakdown of wood cell wall
components by the organism and a start of growth metabolism.

•

Enzyme activity was an indication of the amount of ICL and GLOXDH present in
the crude-homogenate mixture for a particular isolate. ICL production was
significantly higher than GLOXDH production for an individual isolate, which
could imply the presence of both mitochondrial (TCA cycle) and glyoxysome
(GLOX cycle) ICL activity. Because the crude-homogenate was used to measure
enzyme activity, differentiating between mitochondrial ICL or glyoxysome ICL
would be impossible.

•

The lack of activity for FUM, MS, and OAA in individual isolates could have
been caused by a number of factors:
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•

inefficiency to break open the cell wall and release intracellular
enzymes

•

interference of extracellular proteins in the crude-homogenate
mixture

•

expression levels were undetectable because they are present in
such low quantities

•

The primers designed to measure ICL and GLOXDH expression (Table 2.1)
targeted the ICL and GLOXDH present in the glyoxysome (Figure 3.24; based on
Tang 2011 genome). Since the ICL enzyme activity does not reflect the measured
ICL expression levels, it is highly likely that the enzyme activity measured
represents both mitochondrial ICL and glyoxysome ICL. Both ICL and
GLOXDH expression levels correlate to one another, which could also indicate
that measured ICL enzyme activity was due to both mitochondrial and
glyoxysome ICL.

•

Metabolically, CS, ANTI, ICL, and GLOXDH feed into each other (Figure 3.24).
Expression levels of these four genes are connected in the individual isolates. For
example, in L-9414-SP, expression levels of the four genes, CS (4.72), ANTI
(6.96), ICL (5.35), and GLOXDH (5.65), all increase proportionally when
exposed to CC at week 2. Based on this connection, it is likely that these four
genes play a key role in the synthesis of oxalate as an adaptive mechanism when
exposed to copper.

•

It can be suggested that the ATPase pump functions in the organism’s ability to
adapt to a copper-rich environment based on the elevated expression levels in all
treated samples as seen in this study (Figure 3.22). In the presence of copper the
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expression of ATPase increased, which could be a response to an absence of
oxalate. During this adaptation to copper phase, the fungus needs oxalate to tie up
the copper. When initial oxalate levels are low, the ATPase pump would need to
expel toxic levels of copper from the cell. As oxalate binds with copper making it
inert, the ATPase pump should work less and expression levels decrease
accordingly.
•

If it is assumed that the ATPase pump indicates the adaptation phase in a copperrich environment it can be inferred:
•

L-11659-SP seems to have adapted by week 6 (ATPase expression
is much higher in CC than UN at weeks 2 and 4 then decreases by
week 6).

•

FP-90848-T seems to have adapted by week 8 (ATPase expression
is higher in CC than UN through week 6 and decreases by week 8).

•

TFFH 294 has not yet adapted (ATPase expression is higher in CC
than UN through week 8).

•

L-9414-SP has not yet adapted (ATPase expression is higher in CC
than UN through week 8).

•

If oxalate is needed to detoxify copper, it would be expected that the individual
isolates need to continue producing oxalate until the majority of the copper is
bound. From this it can be inferred:
•

L-11659-SP shows higher oxalate production in CC than UN at
week 4. Both CC and UN treatments at week 6 and 8 have similar
oxalate production. This could suggest that by week 6, L-11659-SP
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has bound up the excess copper and no longer needs to produce
higher amounts of oxalate.
•

FP-90848-T shows higher oxalate production in CC than UN at
weeks 6 and 8 suggesting it requires oxalate through week 8.

•

TFFH 294 shows higher oxalate production in CC than UN at
week 6 but not at week 8. This could suggest that the organism has
not fully adapted to the environment by week 8 and still requires
oxalate to some degree.

•

L-9414-SP shows higher oxalate production in CC than UN at
week 8 which could also indicate that the organism has not fully
adapted to the environment at this particular stage.

•

Assuming that adaptation and oxalate production are related in these four isolates
it can be inferred:
•

L-11659-SP has adapted by week 4. Expression indicated higher
levels of CS, AN, and GLOXDH in CC than UN, which generated
a jump in oxalate production at week 4. It is possible that the
highest expression increase occurred before week 2, indicating the
possibility that this isolate is metabolically ahead of the other three
in relation to adapting to copper.

•

FP-90848-T has adapted by week 8. Expression of the four
metabolic genes did not increase in CC treated wood; however,
there was an increase in GLOXDH enzyme activity at weeks 2, 4,
and 8 in CC treated wood. This could indicate that FP-90848-T
utilizes different isozymes of these genes to produce oxalate.
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•

TFFH 294 has not yet adapted. There is an increased GLOXDH
expression at week 2, but not in the other metabolic genes. There
is also a slight increase in GLOXDH enzyme activity for this
isolate. However, it is unclear as to how oxalate is being produced
in this isolate. It could be possible that TFFH 294 is more efficient
in oxalate production, which could require less enzyme expression.

•

L-9414-SP has not yet adapted. Expression of the four metabolic
genes was highly increased at week 2 in CC treated wood. It is
possible that the expression of genes in week 2 lead to the
increased production of oxalate at week 8. This would suggest that
in this isolate it takes approximately 4 weeks to detect increased
oxalate production. Expression levels drop significantly by week
4, which could indicate that L-9414-SP assumed the increased
expression of the four metabolic genes at week 2 will generate
enough oxalate to adapt to the copper-rich environment.

•

This research tracked the production of oxalate from expression of the four key
genes to detection of oxalate outside the fungal cell walls in the four isolates.

•

Two of the isolates followed similar paths to oxalate production, and
interestingly, these same two isolates were most closely related with 99.1%
identity (Appendix 1). All isolates varied with respect to oxalate levels, timing of
production, enzyme activity, and gene expression.

•

Further studies are need to “fine tune” these differences and similarities and
should include earlier sampling times and compression tests to estimate stage of
decay.
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Table A.1

Analysis of gene expression for ICL. Data analyzed by the comparative CT
method (Livak and Schmittgen 2001).

Isolate

Treatment

Time Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

2 Weeks
4 Weeks
6 Weeks
8 Weeks
Week 2
Week 4
Week 6
Week 8

Fold Change
(2-ΔΔCT )
0.398
0.259
1.613
0.207
0.483
0.697
0.702
0.586

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.047
0.105
0.084
0.191
0.080
0.382
0.232
0.132

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.463
0.308
0.196
0.503
0.308
1.000
0.426
1.141

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

5.352
0.126
0.110
0.145
0.245
0.179
0.067
0.084
120

Table A.2

Analysis of gene expression for GLOXDH. Data analyzed by the
comparative CT method (Livak and Schmittgen 2001).

Isolate

Treatment

Time Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

2 Weeks
4 Weeks
6 Weeks
8 Weeks
Week 2
Week 4
Week 6
Week 8

Fold Change
(2-ΔΔCT )
2.085
0.189
1.248
0.291
0.316
0.790
0.607
0.483

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.032
0.052
0.090
0.104
0.036
0.334
0.117
0.332

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.395
0.107
0.102
0.412
0.102
1.000
0.225
0.697

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

5.657
0.127
0.072
0.120
0.132
0.132
0.048
0.085
121

Table A.3

Analysis of gene expression for CS. Data analyzed by the comparative CT
method (Livak and Schmittgen 2001).

Isolate

Treatment

Time Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

2 Weeks
4 Weeks
6 Weeks
8 Weeks
Week 2
Week 4
Week 6
Week 8

Fold Change
(2-ΔΔCT )
2.250
0.747
2.282
1.347
1.257
1.141
1.526
0.742

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.314
0.243
0.245
0.470
0.426
0.920
0.356
0.418

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.920
0.727
0.578
0.768
0.693
1.000
0.940
1.505

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

4.724
0.354
0.268
0.354
0.620
0.758
0.225
0.511
122

Table A.4

Analysis of gene expression for ANTI. Data analyzed by the comparative
CT method (Livak and Schmittgen 2001).

Isolate

Treatment

Time Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

2 Weeks
4 Weeks
6 Weeks
8 Weeks
Week 2
Week 4
Week 6
Week 8

Fold Change
(2-ΔΔCT )
3.294
1.625
1.972
0.688
1.602
1.693
1.840
1.414

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

0.398
0.877
0.540
1.404
0.660
1.094
0.763
0.953

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

1.079
0.655
0.877
0.933
1.133
1.000
0.940
1.495

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

6.964
0.707
0.646
0.669
0.722
0.933
0.463
0.473
123

Table A.5

Analysis of gene expression for ATPase. Data analyzed by the comparative
CT method (Livak and Schmittgen 2001).

Isolate

Treatment

Time Point

L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP
L-11659-SP

CC
CC
CC
CC
UN
UN
UN
UN

2 Weeks
4 Weeks
6 Weeks
8 Weeks
Week 2
Week 4
Week 6
Week 8

Fold Change
(2-ΔΔCT )
15.348
15.455
2.144
1.986
6.021
1.526
1.474
2.497

FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T
FP-90848-T

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

8.634
5.579
10.556
2.129
3.784
0.470
0.785
0.859

TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294
TFFH 294

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

9.254
2.990
2.928
2.219
1.240
1.000
1.741
0.366

L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP
L-9414-SP

CC
CC
CC
CC
UN
UN
UN
UN

Week 2
Week 4
Week 6
Week 8
Week 2
Week 4
Week 6
Week 8

9.849
8.456
13.548
7.464
4.469
3.364
4.823
2.000
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Figure A.1

Sequence distances based on percent identity and divergence of four F.
radiculosa isolates.

Figure A.2

Phylogenetic tree of four F. radiculosa isolates based on sequence
distances (nucleotide substitutions).

125

